# Chapter 29: Persistent Depressive Disorder

## The Biological and Neurological Basis of Persistent Depressive Disorder

### Introduction

Persistent Depressive Disorder (PDD), also known as dysthymia, represents a chronic and pervasive form of depression that presents significant challenges to both individuals and clinicians (Finlayson, 1989; Moch, 2011). Unlike Major Depressive Disorder (MDD), which is characterized by discrete episodes of severe depression lasting at least two weeks (Bains et al., 2021; Sheets & Brosse, 2010), PDD is defined by a more enduring, though often less severe, disturbance of mood (Finlayson, 1989; Bénony et al., 2012). The diagnostic criteria require a depressed mood for most of the day, for more days than not, for at least two years in adults, or one year in children and adolescents (Finlayson, 1989; Steffens et al., 2013). This chronic low mood is accompanied by associated symptoms such as poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor concentration or difficulty making decisions, and feelings of hopelessness (Finlayson, 1989; Steffens et al., 2013).

The chronicity of PDD is its defining feature, often leading patients to perceive their depressive symptoms as an integral part of their personality (Akiskal, 1980; Devanand, 2004). This long duration contributes to substantial psychosocial impairment, affecting social, occupational, and interpersonal functioning (Moch, 2011; Agarwal et al., 2021). The morbidity associated with dysthymia can be as serious as that of MDD due to the persistence of the distressing syndrome (Moch, 2011; Scott, 1988). Furthermore, individuals with PDD are at an increased risk of developing superimposed episodes of MDD, a condition sometimes referred to as "double depression" (Scott, 1988; Kocsis & Brody, 2013).

From a biological and neurological perspective, understanding PDD is a complex endeavor. The available research literature, while extensive on mood disorders broadly, often focuses on episodic MDD or bipolar disorder, leaving the specific neurobiology of chronic, low-grade depression less clearly defined (Juruena, 2012). However, by examining the biological underpinnings of depression as a spectrum of disorders (López-Ibor, 1990; Wïttchen, 2001), we can infer and construct a model for the neurobiological basis of PDD. Depressive disorders are understood to result from a complex interplay of genetic, environmental, psychological, and biological factors (Koo, 2018; Sengupta et al., 2019). The chronicity inherent in PDD suggests that underlying biological systems may be in a state of sustained dysregulation rather than episodic disruption.

This chapter will synthesize the available evidence to construct a comprehensive overview of the biological and neurological mechanisms implicated in PDD. We will explore the roles of neurotransmitter systems, the structure and function of neural circuits, and genetic and molecular contributions. Neuroimaging findings, developmental considerations, and the biological implications of treatment will be discussed. By integrating findings from studies on major depression, chronic stress, and related mood disorders, this chapter aims to provide a coherent, evidence-based framework for understanding the enduring nature of PDD from a neurobiological standpoint, acknowledging that much of the direct evidence is extrapolated from related conditions due to the specific focus of the available literature.

### Neurobiological Systems

The neurobiological underpinnings of Persistent Depressive Disorder are best understood by examining the systems implicated in mood regulation more broadly, as depressive disorders are considered to exist on a continuum of severity and chronicity (Juruena, 2012; Wïttchen, 2001). The enduring nature of PDD suggests a stable, long-term dysregulation within these systems, rather than the more acute fluctuations seen in episodic depression (Scott, 1988). Key areas of investigation include neurotransmitter function, the neuroendocrine stress response, and inflammatory processes.

#### Neurotransmitter Systems and Neuropharmacology

The monoamine hypothesis has long served as a foundational model for understanding depression, positing that the disorder arises from a functional deficiency of key neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA) (Fiar et al., 2012; Khune et al., 2023; Pavana Keerthi et al., 2014). While this model is now considered an oversimplification, these neurotransmitter systems remain central to the pathophysiology and treatment of depressive states (Chaudhry, 2020).

**Serotonin (5-HT):** The serotonergic system is deeply implicated in mood, sleep, appetite, and cognitive function, all of which are disturbed in PDD (Finlayson, 1989). Dysfunction in serotonin pathways is a plausible mechanism for the chronic low mood, anxiety, and vegetative symptoms seen in the disorder (Arbuck, 2022). The efficacy of selective serotonin reuptake inhibitors (SSRIs) like fluoxetine and sertraline in treating depressive and anxious symptoms provides strong pharmacological evidence for serotonin's role (Montgomery et al., 1993; Moch, 2011; Seiner et al., 2021). The development of serotonin syndrome, a potentially life-threatening condition caused by excessive serotonergic activity, underscores the power of this system in regulating central and peripheral functions (Scotton et al., 2019). Studies on serotonin receptor subtypes, such as 5-HT1A and 5-HT2A, are crucial for understanding the nuanced effects of serotonergic agents (Scotton et al., 2019; Willner, 1984). The chronic nature of PDD may involve long-term adaptations or plastic changes in these receptor systems (Chouinard & Chouinard, 2015).

**Norepinephrine (NE):** The noradrenergic system is critical for arousal, alertness, concentration, and energy levels (Briley, 2011; Fiar et al., 2012). Symptoms of PDD such as fatigue, low energy, and poor concentration align with deficits in this system (Finlayson, 1989; Briley, 2011). Antidepressants that target both serotonin and norepinephrine (SNRIs), such as venlafaxine and duloxetine, have demonstrated efficacy in treating depression, suggesting that dual-action mechanisms may be beneficial, particularly for symptoms like lassitude and retardation of thoughts (Tollefson et al., 1993; Briley, 2011; Solmi et al., 2019). The interaction between the noradrenergic system and the stress response further implicates it in chronic mood disorders (Charmandari et al., 2003).

**Dopamine (DA):** The dopaminergic system is fundamental to motivation, pleasure, and reward (Fiar et al., 2012). Anhedonia, the loss of interest or pleasure, is a core symptom of depression and is particularly relevant to the persistent lack of enjoyment seen in PDD (Bains et al., 2021; Kennedy, 2008). Dopamine dysfunction is hypothesized to underlie symptoms of low motivation, apathy, and anhedonia (Arbuck, 2022; Fiar et al., 2012). The involvement of dopamine may also help differentiate certain depressive subtypes, and agents that modulate dopamine, such as bupropion, can be effective treatments (Keck et al., 2007; Carroll & Rado, 2009). Furthermore, interactions between dopamine and other systems, such as the glutamate system, are increasingly recognized as important for synaptic plasticity and mood regulation (Tomasetti, 2014).

**Glutamate and GABA:** Beyond the monoamines, the primary excitatory (glutamate) and inhibitory (gamma-aminobutyric acid, GABA) neurotransmitter systems are critical for overall brain function and are implicated in depression (Tomasetti, 2014; Yarlagadda et al., 2007). Dysregulation in glutamate signaling, particularly through the N-methyl-D-aspartate (NMDA) receptor, is a target for novel, rapid-acting antidepressants like ketamine (Ghaisani, 2018; Li & Loshak, 2019). The GABAergic system is a primary target for anxiolytic medications like benzodiazepines and is also involved in mood regulation (Yarlagadda et al., 2007; Sakakibara & Katsuragawa, 2022). The chronic nature of PDD may involve sustained imbalances in the excitation-inhibition ratio within key neural circuits.

#### Neuroendocrine and Neuroinflammatory Systems

The body's stress response system, primarily the hypothalamic-pituitary-adrenal (HPA) axis, is consistently implicated in mood disorders (Juruena, 2012; van Praag et al., 2004). Chronic stress is a well-established risk factor for the onset of depression (Schneiderman et al., 2004; House, 1987). In individuals with PDD, who experience a long-term depressive state, the HPA axis may be in a state of chronic dysregulation (Meyer & Hamel, 2014).

Under stressful conditions, the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the pituitary to release adrenocorticotropic hormone (ACTH), in turn prompting the adrenal glands to secrete cortisol (Charmandari et al., 2003). In many patients with major depression, this system is hyperactive, leading to elevated cortisol levels and impaired negative feedback, a phenomenon observable through tests like the dexamethasone suppression test (DST) (Pottash, 1981; Steinberg, 1981). Studies in high-risk adolescents have shown that higher cortisol levels, in conjunction with life events, predict the onset of major depression (Goodyer et al., 2000). The persistent, low-grade stress characteristic of the PDD experience may perpetuate this HPA axis hyperactivity, contributing to both psychological symptoms and physical comorbidities (Juruena, 2012; Anisman et al., 2005).

Closely linked to the HPA axis is the neuroinflammatory system. Proinflammatory cytokines, such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), are signaling molecules of the immune system that can act on the brain to produce "sickness behaviors," which overlap significantly with depressive symptoms like fatigue, anhedonia, and social withdrawal (Anisman et al., 2005; Helgesen, 2019). Chronic stress can promote a proinflammatory state (Khanam, 2017), and elevated cytokine levels have been observed in patients with severe depression (Anisman et al., 2005). This inflammatory activity can further drive HPA axis dysregulation, creating a vicious cycle that may contribute to the chronicity of PDD (Anisman et al., 2005; Maj, 2023). Therefore, the biological landscape of PDD likely involves a complex interplay between neurotransmitter imbalances, sustained HPA axis hyperactivity, and a low-grade, chronic inflammatory state, which together maintain the persistent depressive symptomatology.

### Genetic and Molecular Basis

The development of Persistent Depressive Disorder, like other mood disorders, is not attributable to a single cause but rather to a complex interaction of genetic vulnerabilities and environmental factors (Koo, 2018; Sengupta et al., 2019). While the specific genetic architecture of PDD is less studied than that of MDD or bipolar disorder, evidence from family, twin, and adoption studies robustly supports a heritable component for depressive disorders in general (Cadoret & Winokur, 1972; Hatcher-Kay & King, 2003). This genetic predisposition establishes a biological vulnerability that, when combined with psychosocial stressors or adverse life events, increases the likelihood of illness onset (Schneiderman et al., 2004; Rice et al., 2002).

#### Heritability and Family Studies

Family studies have consistently shown that mood disorders aggregate within families (Cadoret & Winokur, 1972). First-degree relatives of individuals with depressive disorders have a higher risk of developing depression themselves (Hatcher-Kay & King, 2003). Similarly, a family history of affective illness is a significant risk factor for chronic depression (Akiskal, 1982). Twin studies provide further evidence for a genetic contribution, demonstrating higher concordance rates for MDD in genetically identical (monozygotic) twins compared to fraternal (dizygotic) twins (Rice et al., 2002; Vonk, 2016). While these studies often focus on MDD or bipolar disorder, the findings are considered relevant to the broader spectrum of mood disorders, including PDD (López-Ibor, 1990; Akiskal, 1980). The familial nature of PDD may also be linked to shared environmental factors, such as dysfunctional family dynamics or exposure to early adversity, which can interact with genetic predispositions (Zharikov, 1991; VANVALKENBURG et al., 1987).

#### Candidate Genes and Molecular Mechanisms

Research into the molecular basis of depression has moved from broad heritability estimates to the identification of specific candidate genes and pathways. Much of this work has centered on genes involved in the regulation of the neurotransmitter systems implicated in depression, particularly the serotonin system (Arbuck, 2022). For instance, polymorphisms in the serotonin transporter gene have been investigated for their role in moderating the effects of life stress on the development of depression (Hatcher-Kay & King, 2003), although this specific gene-environment interaction has been a subject of ongoing debate. Other genes related to dopamine, norepinephrine, and neurotrophic factors like brain-derived neurotrophic factor (BDNF) are also areas of active investigation (Fiar et al., 2012; Tomasetti, 2014).

The chronicity of PDD suggests that epigenetic mechanisms may play a crucial role. Epigenetics refers to modifications to DNA that do not change the DNA sequence itself but alter gene activity and expression. Chronic stress and early life adversity—known risk factors for depression (Schneiderman et al., 2004; Ferrara, 2014)—can induce lasting epigenetic changes, such as DNA methylation, that affect the expression of genes involved in the stress response and neural plasticity (Meyer & Hamel, 2014). Such mechanisms could provide a molecular basis for how early negative experiences become biologically embedded, creating a long-term vulnerability to chronic depressive states like PDD (Ferrara, 2014).

Furthermore, the molecular basis of PDD likely involves disruptions in intracellular signaling pathways that are downstream of neurotransmitter receptors. These pathways are involved in fundamental processes like synaptic plasticity, neurogenesis, and cell survival (Tomasetti, 2014). Chronic dysregulation of monoamine systems could lead to maladaptive changes in these intracellular cascades, contributing to the structural and functional brain abnormalities observed in mood disorders (Dell’Osso et al., 2012). For example, pathways involving molecules like cyclic AMP (cAMP), protein kinase A (PKA), and transcription factors such as CREB (cAMP response element-binding protein) are critical for long-term synaptic changes and are influenced by both antidepressants and chronic stress (Willner, 1984).

Finally, investigations into the molecular underpinnings of PDD must consider its heterogeneity. Different clinical presentations, such as early- versus late-onset dysthymia or the presence of atypical features, may reflect distinct underlying genetic and molecular profiles (Akiskal, 1980; Prieto & León González, 2004). For example, early-onset dysthymia, often described as "characterological," may involve a stronger genetic loading for personality traits like neuroticism, which itself has a heritable component (Lewinsohn et al., 1977; Akiskal, 1982). In contrast, late-onset dysthymia may be more closely linked to somatic diseases and cerebrovascular changes that emerge later in life (Prieto & León González, 2004). Understanding this molecular and genetic diversity is essential for developing more targeted and effective treatments for this persistent and disabling disorder.

### Brain Structure and Function

The chronic nature of Persistent Depressive Disorder suggests that it is associated with enduring alterations in both the structure and function of the brain's mood-regulating circuits (MacKinnon, 2015). While neuroimaging research specifically targeting PDD is less extensive than for MDD or bipolar disorder, findings from the broader field of depressive disorders provide a strong basis for understanding the neural correlates of chronic depressive states (Chen & Gong, 2021; Dell’Osso et al., 2012). These studies consistently point to dysregulation within a network of interconnected cortical and subcortical regions.

#### Key Brain Regions Implicated in Depression

The neuroanatomy of mood disorders involves a distributed network rather than a single "lesion" site (Dreyer-Oren et al., 2018). Key regions implicated include the prefrontal cortex (PFC), anterior cingulate cortex (ACC), hippocampus, and amygdala (Ruiz‐Rizzo & Lópera Restrepo, 2008; Meyer & Hamel, 2014).

*   **Prefrontal Cortex (PFC):** The PFC, particularly the dorsolateral (DLPFC) and ventromedial (VMPFC) subregions, is crucial for executive functions, emotional regulation, and decision-making (Frodl, 2023; Frommann et al., 2010). In depression, hypoactivity in the DLPFC is often observed, which may relate to symptoms of psychomotor retardation, apathy, and cognitive deficits such as poor concentration and indecisiveness (Nasrallah, 2014; Ruiz‐Rizzo & Lópera Restrepo, 2008). Conversely, the VMPFC and orbitofrontal cortex (OFC) can show hyperactivity, potentially related to the processing of negative emotional stimuli and rumination (Nasrallah, 2014). Structural studies have reported volume reductions in frontal lobe gray matter in patients with mood disorders (Dell’Osso et al., 2012; Dodd, 2007).

*   **Anterior Cingulate Cortex (ACC):** The ACC is a critical hub for integrating emotional and cognitive information (Nasrallah, 2014). The subgenual ACC, in particular, has been a major focus in depression research. This region often shows metabolic hyperactivity in depressed states, which tends to normalize with successful treatment (Sahakian & Morein‐Zamir, 2011). Its hyperactivity is thought to be linked to the pervasive sadness and negative affect characteristic of depression (Frodl, 2023).

*   **Hippocampus:** The hippocampus is vital for learning, memory, and contextual processing, and it also plays a key role in regulating the HPA axis (Meyer & Hamel, 2014). Chronic stress and elevated cortisol levels, often seen in depression, are known to be detrimental to hippocampal neurons, leading to reduced neurogenesis and volume loss (Juruena, 2012; Ruiz‐Rizzo & Lópera Restrepo, 2008). Hippocampal atrophy is one of the more consistent structural findings in recurrent and chronic depression and may underlie the cognitive impairments, particularly memory deficits, seen in these patients (Dell’Osso et al., 2012; Ruiz‐Rizzo & Lópera Restrepo, 2008).

*   **Amygdala:** The amygdala is central to processing fear, threat, and salient emotional stimuli (Frodl, 2023). In depression, the amygdala is often hyperactive, especially in response to negative emotional cues, contributing to symptoms of anxiety, irritability, and a negative cognitive bias (Nasrallah, 2014; Meyer & Hamel, 2014). This heightened reactivity may be a core feature of the vulnerability to depression.

#### Neural Circuits and Functional Connectivity

Modern neuroimaging techniques, particularly resting-state functional magnetic resonance imaging (rs-fMRI), have shifted the focus from individual brain regions to the functional connectivity within and between large-scale brain networks (Chen & Gong, 2021). Depression is increasingly viewed as a disorder of disrupted neural circuitry (Dell’Osso et al., 2012).

The **Default Mode Network (DMN)**, a network of brain regions (including parts of the medial PFC, posterior cingulate cortex, and precuneus) that is active during rest and self-referential thought, is often hyperactive and hyperconnected in depression (Chen & Gong, 2021). This may be the neural substrate for the excessive rumination, self-criticism, and feelings of worthlessness common in PDD (Finlayson, 1989; Frodl, 2023).

The **Salience Network (SN)**, anchored by the anterior insula and dorsal ACC, is responsible for detecting and orienting attention to important internal and external stimuli. In depression, this network may show altered connectivity, potentially leading to a heightened focus on negative internal states and somatic symptoms (Lam, 2018).

The **Central Executive Network (CEN)**, involving the DLPFC and posterior parietal cortex, is engaged during cognitively demanding tasks. In depression, connectivity within the CEN and between the CEN and other networks is often disrupted, which may explain deficits in executive functions like concentration and decision-making (Chen & Gong, 2021; Solmi et al., 2019).

The chronic state of PDD likely reflects a deeply entrenched, stable pattern of dysfunctional connectivity. For instance, the top-down regulatory control of the PFC over the hyperactive amygdala is often weakened, a finding that provides a circuit-level explanation for difficulties in emotion regulation (Frodl, 2023). The persistent low mood and anhedonia of PDD may be sustained by this impaired fronto-limbic regulation, coupled with the DMN's relentless focus on negative self-related thoughts. These altered functional states, over the long course of PDD, may contribute to the subtle but significant structural changes, such as hippocampal volume loss, that are observed in chronic depressive illness (Ruiz‐Rizzo & Lópera Restrepo, 2008).

### Developmental Neurobiology

Persistent Depressive Disorder can have its onset in childhood or adolescence, and this early onset is associated with a more pernicious course and greater impairment (Finlayson, 1989; Jidhun & Chitra, 2016). Understanding the developmental neurobiology of PDD requires examining how genetic vulnerabilities and environmental adversities interact during critical periods of brain maturation to shape the trajectory toward chronic depression (Hatcher-Kay & King, 2003; Meyer & Hamel, 2014).

#### Onset in Childhood and Adolescence

The diagnosis of PDD (dysthymia) in children and adolescents requires a duration of only one year, as opposed to two years for adults, and the mood may present as irritability rather than sadness (Finlayson, 1989; Hatcher-Kay & King, 2003). Depressive disorders are increasingly recognized in youth, with prevalence rates rising sharply during adolescence, particularly for girls (Essau & Petermann, 1995; Hatcher-Kay & King, 2003). Early-onset depression is not a transient phase but a serious condition that predicts recurrent episodes and long-term psychosocial disability (Clarizio, 1989; Gehlawat & Kumar, 2020). Children with early-onset PDD often display a "characterological" profile, where depressive symptoms are deeply integrated into their personality and self-concept (Akiskal, 1980; Devanand, 2004).

The adolescent brain undergoes significant remodeling, particularly in the prefrontal cortex and limbic system, which are central to mood regulation (Sharma et al., 2014). This period of heightened neuroplasticity represents a window of both vulnerability and opportunity (Charmandari et al., 2003). Exposure to chronic stress, trauma, or neglect during this time can disrupt the maturation of these circuits, potentially leading to the entrenchment of depressive patterns (Ferrara, 2014; Meyer & Hamel, 2014). For example, adverse childhood experiences can lead to long-term alterations in HPA axis function and inflammatory responses, creating a biological predisposition for mood disorders (van Praag et al., 2004; Ferrara, 2014). Studies have shown that early traumatic life events are associated with the intensity and clinical picture of depression in later life (Sołtys et al., 2005).

#### Prodromal States and Risk Factors

The pathway to chronic depression often begins long before the full criteria for the disorder are met (Yung, 2011). The concept of a "prodrome" involves a period of subthreshold symptoms and functional decline that precedes the first major episode (Salokangas & McGlashan, 2008). In the context of PDD, this prodromal phase may be particularly insidious, blending into what is perceived as the child's temperament or personality (Akiskal, 1980). Early manifestations can be non-specific, including anxiety, social withdrawal, academic difficulties, and irritability (Salokangas & McGlashan, 2008; Hatcher-Kay & King, 2003).

Several risk factors during development increase the likelihood of early-onset PDD. A family history of mood disorders is a potent risk factor, reflecting genetic vulnerability (Hatcher-Kay & King, 2003; Cadoret & Winokur, 1972). Parental depression, in particular, contributes both a genetic loading and an environmental risk through impaired parenting and family stress (Prager, 2009). Psychosocial adversities, such as childhood abuse or neglect, bullying, and family discord, are also strongly implicated (Ferrara, 2014; Seifert, 2014). These experiences can shape a child's developing brain, leading to heightened stress sensitivity and maladaptive cognitive schemas (Meyer & Hamel, 2014).

Furthermore, comorbid neurodevelopmental disorders, such as Attention-Deficit/Hyperactivity Disorder (ADHD), are common in youth who develop depression (Mehler‐Wex, 2012; Burgić Radmanović & Burgić, 2020). The chronic academic and social struggles associated with ADHD can lead to low self-esteem and feelings of hopelessness, paving the way for a depressive disorder (Sürig & Purper‐Ouakil, 2016). The symptom overlap between ADHD (e.g., inattention, irritability) and depression can complicate diagnosis and suggests shared neurobiological pathways (Kopp & Gillberg, 2022; Lazaratou, 2013).

In summary, the developmental neurobiology of PDD is shaped by a confluence of factors. A genetic predisposition interacts with the environment during the sensitive periods of childhood and adolescent brain development. Chronic stress and adversity can alter the trajectory of neural maturation, leading to the early and persistent patterns of emotional dysregulation that define early-onset PDD. This developmental perspective underscores the importance of early identification and intervention to mitigate the long-term consequences of this chronic disorder (Stănescu et al., 2021).

### Treatment Mechanisms

The treatment of Persistent Depressive Disorder, like other depressive conditions, aims to achieve remission of symptoms and restore psychosocial functioning (Burt, 2004). The biological mechanisms of these treatments, both pharmacological and psychotherapeutic, are thought to involve the modulation of the same neurobiological systems implicated in the disorder's pathophysiology. Given the chronic nature of PDD, treatment often needs to be long-term to prevent relapse and recurrence (Scott, 2000; Malt, 1996).

#### Pharmacological Interventions

Pharmacotherapy for PDD largely mirrors that for MDD, with antidepressants being the mainstay of treatment (Moch, 2011; MacKinnon, 2015). The efficacy of these agents provides further evidence for the neurobiological substrates of the disorder.

*   **Selective Serotonin Reuptake Inhibitors (SSRIs):** SSRIs, such as fluoxetine, sertraline, and escitalopram, are often considered first-line agents due to their favorable side-effect profile and safety in overdose compared to older antidepressants (Montgomery et al., 1993; Ganasan, 2019). SSRIs act by blocking the presynaptic reuptake of serotonin, thereby increasing its availability in the synaptic cleft (Scotton et al., 2019). While this acute action occurs rapidly, the therapeutic antidepressant effect typically takes several weeks to emerge, suggesting that the long-term effects of increased serotonergic transmission are crucial (Willner, 1984). These downstream effects are believed to include changes in receptor sensitivity, gene expression, and ultimately, neuroplasticity within mood-regulating circuits (Chouinard & Chouinard, 2015). For PDD, the goal is to reverse the chronic state of serotonergic dysregulation.

*   **Other Antidepressants:** Other classes of antidepressants are also effective. Tricyclic antidepressants (TCAs), while effective, have a less favorable side-effect profile, including anticholinergic and cardiotoxic effects (Montgomery et al., 1993). Serotonin-norepinephrine reuptake inhibitors (SNRIs) target both serotonin and norepinephrine systems, which may offer broader efficacy, particularly for symptoms of fatigue and poor concentration (Briley, 2011). Other agents, such as bupropion, which primarily affects dopamine and norepinephrine, may be useful for patients with symptoms of anhedonia and low energy (Carroll & Rado, 2009). The choice of medication is often guided by the patient's specific symptom profile and tolerability (Ganasan, 2019). The need for long-term maintenance therapy is high in PDD to prevent recurrence (Malt, 1996; Scott, 1988).

*   **Augmentation and Combination Strategies:** For patients with treatment-resistant depression, which can be common in chronic forms like PDD, several augmentation strategies are employed (Touloumis, 2021; Bertschy, 2007). These include adding a second agent, such as lithium, a second-generation antipsychotic (e.g., aripiprazole, quetiapine), or another antidepressant with a different mechanism of action (Keck et al., 2007; Bertschy, 2007). The biological rationale for these strategies is to target multiple neurotransmitter systems simultaneously or to modulate downstream signaling pathways that were not sufficiently affected by monotherapy (Tomasetti, 2014). For example, lithium and some antipsychotics are considered mood stabilizers and may influence intracellular signaling cascades involved in neuroprotection and synaptic plasticity (Keck et al., 2007; Maremmani et al., 2010).

#### Psychotherapeutic Interventions

Psychotherapy is a cornerstone of treatment for PDD, either alone for milder forms or in combination with pharmacotherapy, which is often the most effective approach (Moch, 2011; McCullough, 2010). Psychotherapies are not merely "talking cures"; they are believed to induce tangible changes in brain function and structure.

*   **Cognitive Behavioral Therapy (CBT):** CBT helps patients identify and challenge the negative, distorted thought patterns and maladaptive behaviors that maintain depression (Kumara & Kumar, 2016). From a neurobiological perspective, CBT is thought to strengthen top-down cognitive control from the prefrontal cortex over hyperactive limbic regions like the amygdala (Frodl, 2023). By modifying dysfunctional cognitions, CBT may help normalize activity in the default mode network, reducing rumination (Frodl, 2023). The Cognitive Behavioral Analysis System of Psychotherapy (CBASP) was specifically developed for chronic depression and integrates cognitive, behavioral, and interpersonal strategies to address the interpersonal consequences of the patient's behavior (McCullough, 2010).

*   **Interpersonal Therapy (IPT):** IPT focuses on the connection between depressive symptoms and interpersonal problems in areas such as grief, role disputes, and role transitions (Prager, 2009). By improving interpersonal functioning, IPT aims to alleviate depressive symptoms. Its neurobiological mechanism may involve reducing the psychosocial stress that drives HPA axis dysregulation and neuroinflammation (Schneiderman et al., 2004).

The combination of psychotherapy and pharmacotherapy likely has synergistic effects. Medication can provide symptomatic relief (e.g., improving energy and concentration), which enables the patient to engage more effectively in the cognitive and behavioral work of therapy (Burt, 2004). In turn, the skills learned in therapy can promote treatment adherence and provide long-lasting strategies for managing stress and preventing relapse, potentially leading to more resilient and stable changes in neural circuitry than medication alone (Wiles et al., 2016; Carvajal, 2004).

### Future Directions

The study of the biological and neurological basis of Persistent Depressive Disorder (PDD) is an evolving field, and while much has been inferred from research on major depressive and other mood disorders, many questions specific to the chronicity of PDD remain unanswered. Future research must focus on elucidating the unique neurobiological signature of this enduring illness, moving beyond cross-sectional comparisons to embrace longitudinal designs that can capture the trajectory of the disorder from its earliest developmental stages.

One of the most critical areas for future investigation is the differentiation of biological subtypes within the heterogeneous PDD population (Akiskal, 1980; Scott, 1988). The distinction between early-onset ("characterological") and late-onset PDD suggests different underlying etiologies that require distinct research approaches (Prieto & León González, 2004). Future studies should use a combination of genetic, neuroimaging, and endocrine markers to stratify patients and identify distinct biotypes. For example, are there specific genetic markers or endophenotypes associated with early-onset PDD that are not present in late-onset forms (Vonk, 2016)? Does late-onset PDD show a stronger association with markers of cerebrovascular disease and neuroinflammation, as hypothesized (Vasiliu & Vasile, 2016; Luijendijk, 2010)? Answering these questions is fundamental to developing a more precise, personalized approach to treatment.

Advances in neuroimaging will continue to be pivotal. While structural MRI has revealed subtle volume changes in regions like the hippocampus (Ruiz‐Rizzo & Lópera Restrepo, 2008), more advanced techniques are needed. Functional connectivity studies can help map the stable, maladaptive network dynamics that sustain the chronic depressive state in PDD, differentiating them from the more state-dependent changes of episodic MDD (Chen & Gong, 2021). Longitudinal imaging studies that track individuals from high-risk childhood or adolescence through adulthood are essential to understand how brain circuits develop and are altered in the course of PDD (Mehler‐Wex, 2012). Furthermore, techniques like magnetic resonance spectroscopy (MRS) can provide insights into the neurochemical environment, measuring levels of neurotransmitters like glutamate and GABA in key brain regions (Nasrallah, 2014).

The role of the neuroendocrine and immune systems in perpetuating PDD warrants deeper exploration. While HPA axis hyperactivity and inflammation are implicated in depression, their specific dynamics in a chronic, low-grade condition like PDD are not fully understood (Juruena, 2012; Anisman et al., 2005). Research should focus on the long-term consequences of sustained, mild elevations in cortisol and proinflammatory cytokines on synaptic plasticity, neurogenesis, and circuit function (Meyer & Hamel, 2014). This could involve studying epigenetic modifications as a mechanism through which chronic stress and a persistent depressive state become biologically embedded over time (Ferrara, 2014).

From a therapeutic standpoint, future research needs to identify biomarkers that can predict treatment response. Given that a significant portion of patients with chronic depression are treatment-resistant (Touloumis, 2021), identifying which individuals are likely to respond to SSRIs, dual-acting agents, or novel treatments like ketamine is a high priority (Li & Loshak, 2019). This research should also investigate the neurobiological mechanisms of non-pharmacological treatments. How do effective psychotherapies like CBASP or IPT alter brain function and connectivity in patients with PDD (McCullough, 2010)? Understanding these mechanisms could lead to more potent and targeted psychotherapeutic strategies and help optimize the combination of therapy and medication (Carvajal, 2004).

Finally, the boundary between PDD and other chronic conditions, including anxiety disorders, personality disorders, and functional somatic syndromes like chronic fatigue syndrome or fibromyalgia, needs to be clarified at a biological level (Arredondo-Aldana et al., 2021; VANVALKENBURG et al., 1987; Appel et al., 2007). These conditions share significant symptom overlap, particularly in terms of fatigue, pain, and negative affect, and are highly comorbid (Ojha & Kumar, 2021). Future research using a transdiagnostic approach, examining shared and distinct neural, genetic, and inflammatory markers across these disorders, could reveal common pathophysiological pathways and lead to treatments that target core processes rather than diagnostic labels (Fiar et al., 2012; Nasrallah, 2009).

### Conclusion

Persistent Depressive Disorder is a chronic, debilitating mood disorder defined by its enduring nature (Finlayson, 1989; Moch, 2011). While its clinical features of long-standing low mood, low energy, and feelings of hopelessness are well-documented, the underlying biological and neurological mechanisms are still being unraveled, often through inference from the broader study of depressive and mood disorders (Juruena, 2012). This chapter has synthesized the available evidence to build a neurobiological profile of PDD, highlighting the convergence of multiple systems in sustaining this chronic state.

The neurobiology of PDD can be conceptualized as a state of stable dysregulation across interconnected systems. At the level of neurotransmission, chronic imbalances in serotonin, norepinephrine, and dopamine systems are thought to contribute to the core symptoms of depressed mood, anhedonia, and fatigue (Fiar et al., 2012; Briley, 2011). The efficacy of antidepressant medications that target these monoamine systems provides strong, albeit indirect, support for their involvement (Montgomery et al., 1993). Beyond monoamines, emerging evidence points to the crucial role of glutamatergic and GABAergic systems in maintaining the brain's overall excitatory-inhibitory balance, which is likely disrupted in chronic depression (Tomasetti, 2014).

This neurochemical dysregulation does not occur in isolation. It is intricately linked with the body's stress response and immune systems. The hypothalamic-pituitary-adrenal (HPA) axis appears to be in a state of sustained hyperactivity, potentially driven by and contributing to the chronic psychosocial stress inherent in the disorder (van Praag et al., 2004). This, in turn, is associated with a state of low-grade neuroinflammation, where proinflammatory cytokines contribute to the "sickness behaviors" that overlap significantly with PDD symptoms (Anisman et al., 2005). These systems create a self-perpetuating cycle of biological and psychological distress.

Structurally and functionally, PDD is likely a disorder of neural circuits. A network involving the prefrontal cortex, anterior cingulate cortex, hippocampus, and amygdala shows altered activity and connectivity (Chen & Gong, 2021; Dell’Osso et al., 2012). Reduced top-down control from the PFC, coupled with a hyperactive amygdala and a ruminative default mode network, provides a compelling circuit-level model for the persistent negative affect and cognitive biases of PDD (Frodl, 2023). Over the long course of the illness, these functional disturbances may lead to structural changes, such as hippocampal volume reduction (Ruiz‐Rizzo & Lópera Restrepo, 2008).

Genetic factors confer a clear vulnerability to developing PDD, interacting with environmental factors, especially early life adversity, to shape developmental trajectories (Rice et al., 2002; Meyer & Hamel, 2014). The onset of the disorder in childhood or adolescence highlights the importance of neurodevelopmental processes in establishing this chronic condition (Hatcher-Kay & King, 2003).

In conclusion, the biological basis of Persistent Depressive Disorder is multifaceted, involving a complex interplay of genetic predisposition, developmental factors, and a sustained dysregulation of neurotransmitter, neuroendocrine, and neuroinflammatory systems. These disturbances manifest as altered activity and connectivity within the brain's mood-regulating circuits, creating an entrenched state of depression. While current treatments offer relief for many, a deeper understanding of the specific neurobiology of chronicity is essential for developing more effective, targeted interventions to alleviate the profound and lasting burden of this disorder.

## References

1. Abascal, R. R., Sendin, P. M., & Juan, M. E. A. (2008). Adicciones en Anestesiología. Revista de la Escuela de Medicina Legal. https://doi.org/10.5209/rev_reml.2008.n9.50286
2. Abdallah, S. J., Poenaru, S., Corrales‐Medina, V., & Cowan, J. (2021). COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Therapeutic Advances in Infectious Disease. https://doi.org/10.1177/20499361211009385
3. Adams, C. E., Wilson, P., Gilbody, S., Bagnall, A., & Lewis, R. (2000). Drug treatments for schizophrenia. Quality in Health Care. https://doi.org/10.1136/qhc.9.1.73
4. Adetunji, B., Matthews, M., Basil, B., & Oyemade, A. (2007). "Bipolar Family". The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0211e
5. Agarwal, K., Yadav, A. K., Verma, P., & Kaur, B. (2021). DYSTHYMIA AND it’s HOMOEOPATHIC MANAGEMENT. Journal of Emerging Technologies and Innovative Research.
6. Agudelo, D., Spielberger, C. D., & Buela‐Casal, G. (2007). La depresión: ¿un trastorno dimensional o categorial?. Salud Mental.
7. Akiskal, H. S. (1980). Characterological Depressions. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1980.01780200055006
8. Akiskal, H. S. (1982). Factors associated with incomplete recovery in primary depressive illness.. PubMed.
9. Akram, A. S., Sarwar, R., Zafar, M. F., Umair, M., Ullah, I., & Nazir, A. (2023). First oral treatment zuranolone’s FDA approval and its impact on postpartum depression: a new hope – a correspondence. International Journal of Surgery Global Health. https://doi.org/10.1097/gh9.0000000000000345
10. AKTAŞ, S., & Karaaziz, M. (2022). COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF DEPRESSION: A CASE REPORT. SOCIAL SCIENCE DEVELOPMENT JOURNAL. https://doi.org/10.31567/ssd.763
11. Alanbagi, A. A., & Al-Zamily, R. H. (2019). The depression among cancer patients during chemotherapy and its relation to demographic and social data. International Journal of Research in Pharmaceutical Sciences.
12. Alchieri, J. C., & Urquijo, S. (2022). Aspectos demenciais frontotemporais como desafios em processos periciais psicológicos. Revista Psicologia Jurídica Forense. https://doi.org/10.56492/issn.27647374.2022n1a1
13. Aldweik, A. N., Hussain, K. H., & Alhaj, H. (2023). Can Functional Visual Loss Occur in an Older Adult Patient With a History of Stroke: A Case Report. BJPsych Open. https://doi.org/10.1192/bjo.2023.335
14. Alexandre, S., Misery, L., Dutray, S., Chastaing, M., Consoli, S.-M., Audra, H., Bauer, D., Bertolus, S., Callot, V., Cardinaud, F., Corrin, E., Féton-Danou, N., Malet, R., Touboul, S., & Consoli, S. (2007). Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-0266
15. Ali, M., Malathesh, B. C., Chatterjee, S. S., Das, S., & Prasad, S. (2022). Mania/Hypomania induced by quetiapine: A case report and review of literature. Psychiatry Research Case Reports. https://doi.org/10.1016/j.psycr.2022.100093
16. Allan, C. E., Valkanova, V., & Ebmeier, K. P. (2014). Depression in older people is underdiagnosed.. PubMed.
17. Alloy, L. B., & Abramson, L. Y. (2010). Cyclothymic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0249
18. Alvarado, R., Shilling, S., & Jorquera, M. J. (2015). Uso de la Intervención Critical Time Intervention en personas con primer episodio de psicosis. Revista de la Facultad de Ciencias Médicas de Córdoba. https://doi.org/10.31053/1853.0605.v72.n4.13845
19. Amiel, C., & Purper‐Ouakil, D. (2020). [What prescription for psychostimulants in children?]. PubMed.
20. An, T., Ra, Y., Han, C., Kim, H., Lee, K.-S., & Bae, H. (2015). Clinical Correlates of Subtype and Severity in Patients with Delirium. Journal of Korean Neuropsychiatric Association. https://doi.org/10.4306/jknpa.2015.54.4.489
21. anand, I., & Rawal, K. (2022). drug_doc_human_documentation. https://doi.org/10.31219/osf.io/3dnhz
22. Ananto, A. S., & Suryati, E. (2019). Ensefalopati Hipertensi pada Anak dengan Glomerulonefritis Akut Pasca Streptokokal.
23. Andrasik, F., Lipchik, G. L., McCrory, D. C., & Wittrock, D. A. (2005). Outcome Measurement in Behavioral Headache Research: Headache Parameters and Psychosocial Outcomes. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2005.05094.x
24. Anghel, L., Boev, M., Stănescu, C., Caramfil, S. M., Luca, L., Mușat, C. L., & Ciubară, A. (2023). Depression in the Diabetic Patient. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.18662/brain/14.4/526
25. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053381701
26. Antoniuk, S. A. (2013). [Non-epileptic disorders in infancy and adolescence].. PubMed.
27. Appel, S., Chapman, J., & Shoenfeld, Y. (2007). Infection and vaccination in chronic fatigue syndrome: Myth or reality?. Autoimmunity. https://doi.org/10.1080/08916930701197273
28. Arbuck, D. M. (2022). Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 1). Current psychiatry. https://doi.org/10.12788/cp.0242
29. Arbuck, D. M. (2022). Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 2). Current psychiatry. https://doi.org/10.12788/cp.0253
30. Argyriou, A. A., Anastopoulou, G. G., & Bruna, J. (2018). Inconclusive evidence to support the use of minimally-invasive radiofrequency denervation against chronic low back pain. Annals of Translational Medicine. https://doi.org/10.21037/atm.2018.01.23
31. Armstrong, E. (1995). Anxiety and related problems. https://doi.org/10.1007/978-1-349-13362-8_5
32. Arnáez, S. (2019). Vulnerabilidad cognitiva a la hipocondría: intrusiones, valoraciones y creencias disfuncionales/ cognitive vulnerability to hypochondriasis: intrusions, appraisals and dysfunctional beliefs.
33. Arredondo-Aldana, K., Mera-Posligua, M. J., & Alencastro, J. A. P. (2021). Trastorno Depresivo Persistente y Trastornos de Ansiedad Generalizada Proveniente de un Estrés Post Traumático Crónico: Presentación de un Caso Clínico. Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. https://doi.org/10.46296/gt.v4i8edesp.0027
34. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2013). Nonconvulsive status epilepticus and psychotic symptoms: case report.. PubMed. https://doi.org/10.1708/1292.14295
35. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2016). Nonconvulsive status epilepticus and psychotic symptoms: case report Stato epilettico non convulsivo e sintomi psicotici: caso clinico.
36. Athanasou, J. A. (2016). Substance Abuse. SensePublishers eBooks. https://doi.org/10.1007/978-94-6300-657-6_17
37. Avari, J., Yuen, G. S., AbdelMalak, B., Mahgoub, N., Kalayam, B., & Alexopoulos, G. S. (2014). Assessment and Management of Late-Life Depression. Psychiatric Annals. https://doi.org/10.3928/00485713-20140306-04
38. Awan, K., & Steinberg, M. H. (2017). Medical Conditions That May Cause Cognitive Impairment and Depression. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199959549.003.0005
39. Ayoob, A., & Janakiram, C. (2021). Let's Focus on Frailty. Journal of Indian Association of Public Health Dentistry. https://doi.org/10.4103/jiaphd.jiaphd_93_21
40. Bachmann, C. (2015). Padma 28 bei Restless-Legs-Syndrom: Fallberichte wecken Hoffnungen auf Wirksamkeit. Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine. https://doi.org/10.1159/000434622
41. Bains, N., Abdijadid, S., & Miller, J. (2021). Major Depressive Disorder (Nursing).
42. Baldaçara, L., Ramos, A., & Castaldelli-Maia, J. M. (2023). Managing drug-induced psychosis. International Review of Psychiatry. https://doi.org/10.1080/09540261.2023.2261544
43. Balis, G. U. (2018). Syndromes Similar to Functional Disorders. Routledge eBooks. https://doi.org/10.4324/9781315825908-13
44. Ballon, J. S., & Lieberman, J. A. (2010). Advances in the Management of Treatment- Resistant Schizophrenia. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/foc.8.4.foc475
45. Balvir, K. S., Dhanvij, B., Telrandhe, S., & Wajgi, R. D. (2021). A Case Report on Management of Subdural Hematoma. NVEO - NATURAL VOLATILES & ESSENTIAL OILS Journal | NVEO.
46. Bansal, R., & Sheldon, S. H. (2008). Parasomnias in Childhood. CRC Press eBooks. https://doi.org/10.3109/9781420048087-26
47. Barbosa, M. O. S., Silva, F. L. C., Castro, J. D. O., Marino, L. D. B., Silva, V. D. S., Pinho, R. C., & Bonfim, Y. C. (2018). PROCESSO DE ENFERMAGEM EM PACIENTE COM ESQUIZOFRENIA HEBEFRÊNICA: UM RELATO DE CASO. 13º Congresso Internacional Rede Unida.
48. Barnhill, J. W., Hilty, D. M., Gitlin, M., Oquendo, M. A., Cosgrove, V. E., Suppes, T., Findling, R. L., Ferrando, S. J., Daniels, J., Jones, M., & Swartz, H. A. (2023). Bipolar and Related Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615375295.jb03
49. Barreno, E. M., López, M. J. R., & Menéndez, M. J. C. (2003). Trastornos cognitivos y psicóticos en un caso de epilepsia temporal antes y después de la lobectomía.
50. Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014). Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review. Health Technology Assessment. https://doi.org/10.3310/hta18500
51. Batta, A., & Farid, B. (2011). Addiction in Adolescents ---- A Current Trend.
52. Becker, M. A., Weinberger, T. E., & Ocker, L. J. (2022). Mood Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003099062-21
53. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
54. Benítez, N. G. (2018). La neutrosofía para tratar la incertidumbre de trastornos mentales en la tercera edad.
55. Berg, J., & Grimeland, J. (2012). Obsessive-compulsive disorder in disguise—Case report. Open Journal of Psychiatry. https://doi.org/10.4236/ojpsych.2012.23026
56. Berliner, D., Schneider, N., Welte, T., & Bauersachs, J. (2016). The Differential Diagnosis of Dyspnea. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2016.0834
57. Bertodo, T. D. S., Gross, M. S., & Maldaner, E. B. (2018). TRANSTORNOS BIPOLAR E DEPRESSIVO: UMA REVISÃO DOS ASPECTOS CONCEITUAIS.
58. Bertschy, G. (2007). [Resistant depression].. PubMed.
59. Bhingardive, S. S., & Salve, P. (2022). Assessment of Knowledge Regarding Postpartum Psychiatric Disorders Among the Relatives of Primigravida in Selected Hospitals of the City. Acta Scientific Women s Health. https://doi.org/10.31080/aswh.2022.04.0340
60. Bibi, E. S. D. M. (2021). AN OVERVIEW OF POST WAR SOCIAL PROBLEMS IN SYRIA. Pakistan Journal of International Affairs. https://doi.org/10.52337/pjia.v2i2.63
61. Bilal, A., & Naveed, N. (2022). Biological Rhythms, Disorders and their Energetic : A Review. Journal of Internal Medicine Research & Reports. https://doi.org/10.47363/jimrr/2022(1)104
62. Bjorvatn, B., Jernelöv, S., & Pallesen, S. (2021). Insomnia – A Heterogenic Disorder Often Comorbid With Psychological and Somatic Disorders and Diseases: A Narrative Review With Focus on Diagnostic and Treatment Challenges. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2021.639198
63. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
64. Blay, S. L. (2011). A Case of Major Depressive Disorder and Symptoms of Polycystic Ovary Syndrome Responding to Escitalopram. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01183
65. Bloom, B. L. (2004). The Implications Of Controlled Outcome Studies On Planned Short-Term Psychotherapy With Depressive Disorders. https://doi.org/10.1093/oso/9780195165005.003.0029
66. Blumenthal, J. A., & Lett, H. S. (2005). Depression and Cardiac Risk. Journal of Cardiopulmonary Rehabilitation. https://doi.org/10.1097/00008483-200503000-00005
67. Bolten, M., & Légeret, C. (2021). Interface entre pédopsychiatrie et pédiatrie – illustré par le concept bâlois du traitement interdisciplinaire des troubles fonctionnels de la défécation. Paediatrica Métabolisme/maladies rares. https://doi.org/10.35190/f2021.2.1
68. Bolton, E., Holohan, D. R., King, L. A., & King, D. W. (2004). Acute and Post-Traumatic Stress Disorder. Routledge eBooks. https://doi.org/10.4324/9780203336960-13
69. Bond, C., Morgenstern, J., & Milne, W. K. (2022). Hot off the press: <scp>MRI</scp> sensitivity for transient global amnesia. Academic Emergency Medicine. https://doi.org/10.1111/acem.14540
70. Bourdeanu, L., Hein, M. J., & Liu, E. A. (2015). Insomnia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244330.003.0011
71. Boylan, K., & Eppel, A. (2008). The severe mood dysregulation phenotype: case description of a female adolescent.. PubMed.
72. Brashear, A., Sweadner, K. J., Cook, J., Swoboda, K. J., & Ozelius, L. J. (2014). ATP1A3-Related Neurologic Disorders. University of Washington, Seattle eBooks.
73. Bravo, M. D. L. (2011). Ansiedad y depresión en la vejez.
74. Brekke, J. S., Kelly, E. L., Duana, L., Cohena, H., Kigera, H., & Pancake, L. (2019). Can People Who Have Experience with Serious Mental Illness Help Peers Manage Their Health Care?. https://doi.org/10.25302/4.2019.ad.13046650
75. Brieger, P., Hensel, J., & Marneros, A. (2005). Bipolare affektive und schizoaffektive Störungen des höheren Lebensalters. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2004-830246
76. Briley, M. (2011). Noradrenergic symptom cluster in depression. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s19611
77. Brinkmann, B. H. (2021). Mental Disorder Issues in People.
78. Brody, D. L. (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
79. Bromberger, J. T., & Woods, N. F. (2009). Nonhormonal Factors Associated with Psychiatric Morbidity during the Menopausal Transition and Midlife. Key issues in mental health (Online)/Key issues in mental health (Print). https://doi.org/10.1159/000209601
80. Bronstein, A. M., & Lempert, T. (2010). Management of the patient with chronic dizziness. Restorative Neurology and Neuroscience. https://doi.org/10.3233/rnn-2010-0530
81. Bruch, S. (2013). Cultural concerns and issues in emergency psychiatry. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139088077.041
82. Bruin, E. I. D., Meppelink, R., & Bögels, S. M. (2020). Mindfulness in attention deficit hyperactivity disorder. Routledge eBooks. https://doi.org/10.4324/9781315563862-7
83. Buchwald, A. M., & Rudick-Davis, D. (1993). The symptoms of major depression.. Journal of Abnormal Psychology. https://doi.org/10.1037//0021-843x.102.2.197
84. Bueno, B. B., Soares, V. S., & Oliveira, C. F. D. (2014). Patologias associadas à deficiências na síntese do grupo heme. Revista Científica da FHO|Uniararas. https://doi.org/10.55660/revfho.v2i2.101
85. Buist‐Bouwman, M. A. (2007). Functional limitations associated with mental disorders : inescapable fact or avoidable reality?.
86. Bukhari, S. N. A. (2022). Consequences of Antipsychotic Medications on Mental Health. Current Drug Safety. https://doi.org/10.2174/1574886317666220216101106
87. Burgić-Radmanović, M. (2011). Affective disorders in childhood and adolescence. Acta Medica Academica. https://doi.org/10.5644/ama.v40i1.103
88. Burt, V. K. (2004). Plotting the course to remission: the search for better outcomes in the treatment of depression.. PubMed.
89. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Le trouble hyperkinétique ou déficit de l'attention/hyperactivité. Le point sur... Psychologie.
90. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Les troubles de l'humeur. Le point sur... Psychologie.
91. Büyüktuncer, Z., & Isgin, K. (2017). Nutritional approach in premenstrual syndrome. Turkish Bulletin of Hygiene and Experimental Biology. https://doi.org/10.5505/turkhijyen.2017.46667
92. Ca, E., & Petermann, U. (1995). [Depression in children and adolescents].. PubMed.
93. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
94. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Post-Stroke Apathy: An Exploratory Longitudinal Study. Cerebrovascular Diseases. https://doi.org/10.1159/000350202
95. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Supplementary Material for: Post-Stroke Apathy: An Exploratory Longitudinal Study. Figshare. https://doi.org/10.6084/m9.figshare.5124829
96. Callahan, C. M., Austrom, M. G., & Unverzagt, F. W. (2004). Dementia and Late-Life Depression. https://doi.org/10.1093/oso/9780195149395.003.0021
97. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
98. Caraiane, A., Szalontay, A. S., Macovei, L. A., Romila, A., Indrei, L. L., Decusară, M., & Tarc, T. (2018). Oral-Facial Manifestations Caused by the Use of Psychotropic Medication in Psychiatric Patients. Revista de Chimie. https://doi.org/10.37358/rc.18.6.6374
99. Carod-Artal, F. J., Irimia, P., & Ezpeleta, D. (2012). Migraña crónica: definición, epidemiología, factores de riesgo y tratamiento. Revista de Neurología. https://doi.org/10.33588/rn.5410.2012170
100. Carrera, M. A. V., Correa, S. M. V., Prado, M. M. C., & Granados, K. P. M. (2019). Manejo de intoxicación por opioides. RECIMUNDO. https://doi.org/10.26820/recimundo/3.(4).diciembre.2019.494-510
101. Carrión, A., & Eduardo, C. (2015). Dispepsia: ¿Cómo actuar basado en evidencias?, ¿Orgánica o Funcional? ¿Cómo estudiarla y tratarla con fundamento científico?.
102. Carroll, V. K., & Rado, J. (2009). Is a Medical Illness Causing Your Patient's Depression? Endocrine, Neurologic, Infectious, or Malignant Processes Could Cause Mood Symptoms. Current psychiatry.
103. Carvajal, C. (2004). Poor response to treatment: beyond medication. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2004.6.1/ccarvajal
104. Carvajal, C. (2004). Poor response to treatment: beyond medication.. PubMed.
105. Carvajal-Lohr, A., Flores‐Ramos, M., Montejo, S. I., & Vidal, C. G. (2016). Los trastornos de ansiedad durante la transición a la menopausia. Perinatología y Reproducción Humana. https://doi.org/10.1016/j.rprh.2016.03.003
106. CASEY, P., & Bailey, S. (2011). Adjustment disorders: the state of the art. World Psychiatry. https://doi.org/10.1002/j.2051-5545.2011.tb00003.x
107. Castillo-Villanueva, E., Coy, P. E. C., Shejet, F. O., Durán, E. T., & Cabrera, D. M. (2010). Evaluación de funciones cognitivas: atención y memoria en pacientes con trastorno de pánico. Salud Mental.
108. Cha, Y., Baloh, R. W., Cho, C., Magnusson, M., Song, J., Strupp, M., Wuyts, F. L., & Staab, J. P. (2020). Mal de débarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200714
109. Challacombe, F., & Wroe, A. L. (2013). A hidden problem: consequences of the misdiagnosis of perinatal obsessive–compulsive disorder. British Journal of General Practice. https://doi.org/10.3399/bjgp13x667376
110. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
111. Charlton, S. R. (2020). Psychology and Black History Month in the United States. Eye on Psi Chi Magazine. https://doi.org/10.24839/2164-9812.eye24.4.18
112. Charmandari, E., Kino, T., Souvatzoglou, E., & Chrousos, G. P. (2003). Pediatric Stress: Hormonal Mediators and Human Development. Hormone Research in Paediatrics. https://doi.org/10.1159/000069325
113. Charmaz, K. (2007). Chronic Illness and Disability. The Blackwell Encyclopedia of Sociology. https://doi.org/10.1002/9781405165518.wbeosc035
114. Chaudhry, S. (2020). Depression and its Dilemma. IP Journal of Surgery and Allied Sciences. https://doi.org/10.18231/j.jsas.2020.013
115. Chavan, R., Gosavi, M., Baviskar, M., & Goyal, N. P. (2023). Depression Detection using AI, ML and NLP. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-8886
116. Chen, D., & LaFrance, W. C. (2018). Epilepsy and Seizures. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy10
117. Chen, J., Dhillon, D., L'hoeste, J. D., & Low, A. (2022). Bipolar Disorder. The Meducator. https://doi.org/10.35493/medu.42.6
118. Chen, Z., & Gong, Q. (2021). Resting-State Functional Connectivity in Unipolar Depression. Cambridge University Press eBooks. https://doi.org/10.1017/9781108623018.007
119. Chiliza, B., & Vythilingum, B. (2011). Consultation liaison psychiatry in Africa – essential service or unaffordable luxury?. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v14i4.1
120. Choo, K.-Q., Wl, L., How, C., & Ng, B. (2015). Hoarding in Singapore. Singapore Medical Journal. https://doi.org/10.11622/smedj.2015131
121. Chou, C. J. (2009). Mixed Episodes with Psychotic Features. CNS Spectrums. https://doi.org/10.1017/s1092852900003886
122. Chouinard, G., & Chouinard, V. (2015). New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000371865
123. Chrzanowski, D. T., Guthrie, E., Perkins, M., & Rynn, M. A. (2014). Child and Adolescent Psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0015
124. Cienfuegos, J. J., Arriaga, M. Á. A., García, J. J., & Fernández, A. C. S. (2021). Propuesta de establecimiento de hábitos y rutinas que contemplen ejercicio y manejo del estrés para evitar el desgaste laboral durante el home office. Ciencia Latina Revista Científica Multidisciplinar. https://doi.org/10.37811/cl_rcm.v5i3.583
125. Clarizio, H. F. (1989). Continuity in childhood depression.. PubMed.
126. Clayton, A., Dennerstein, L., Pyke, R. E., & Sand, M. (2010). Flibanserin: A Potential Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women. Women s Health. https://doi.org/10.2217/whe.10.54
127. Compton, M. T., & Broussard, B. (2010). Psychosocial Treatments for Early Psychosis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0016
128. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
129. Correll, C. U. (2015). Prevention of Bipolar and Depressive Disorders: is This an Attainable Goal?. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30057-2
130. Corruble, E., Warot, D., & Soubrie, C. (2003). Insomnia linked to medications. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_20
131. Corrêa, C. R. G. L. (2013). Attention – Deficit Hyperactivity Disorder (ADHD) in Psychiatry and Psychoanalysis. InTech eBooks. https://doi.org/10.5772/52880
132. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
133. Cruz, B., Limeres, P. C., Campo, A. C. D., & Soler, A. F. (2021). Depression and hypothyroidism: Literature review and case report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.884
134. Cruz, M. C. D., Camargo, R. P. D., Cruz, L. C. D., Schiefelbein, N., Cruz, D. M. D., & Cruz, M. C. C. D. (2020). Migrânea: revisão de literatura. ARCHIVES OF HEALTH INVESTIGATION. https://doi.org/10.21270/archi.v10i2.4670
135. Cruz, M. P. (2011). Lurasidone HCl (Latuda), an Oral, Once-Daily Atypical Antipsychotic Agent for the Treatment of Patients with Schizophrenia.. PubMed.
136. Császár, N. (2014). The Importance of Psychological Assessment and Support in Patients Suffering from Cardiovascular Disease or Undergoing Cardiac Treatment. Journal of Cardiovascular Diseases & Diagnosis. https://doi.org/10.4172/2329-9517.1000161
137. Cuevas, M. J. S. (2005). EL TRASTORNO POR DÉFICIT DE ATENCIÓN CON HIPERACTIVIDAD (314.01) Y SU INCIDENCIA EN EL MEDIO ESCOLAR, FAMILIAR Y SOCIAL EN EL CAMPO DE GIBRALTAR. Almoraima:  revista de estudios campogibraltareños.
138. Czajkowska‐Malinowska, M., & Cofta, S. (2014). Obturacyjny bezdech senny i jego społeczne następstwa.
139. Dadsetan, P., Lazarus, R. S., & Jahangiri, H. (2019). Stress: Treatment, and Management. LAP LAMBERT Academic Publishing eBooks.
140. Dahm, K. T., Holte, H. H., Dalsbø, T. K., Straumann, G. H., & Reinar, L. M. (2017). Effect of Physical Activity without Use of Antipsychotics Compared to Physical Activity and Antipsychotics for Patients with Active Psychosis: A Systematic Review [Internet].
141. Darwish, L., Beroncal, E. L., Sison, M. V., & Swardfager, W. (2018). Depression in people with type 2 diabetes: current perspectives. Diabetes Metabolic Syndrome and Obesity. https://doi.org/10.2147/dmso.s106797
142. Das, C., & Joseph, S. (2005). Falls in elderly.. PubMed.
143. Dashinie, S., & Renganathan, S. (2014). Major Depressive Disorder without Psychotic Features- A Case Report.
144. Delanerolle, G., Shetty, S., Raymont, V., Hapangama, D. K., Haque, N., Shi, J. Q., Ayis, S., Shetty, A., & Phiri, P. (2021). None. LOJ Medical Sciences. https://doi.org/10.32474/lojms.5.5
145. Delgado, S., Wassenaar, E., & Strawn, J. R. (2011). Does Your Patient Have a Psychiatric Illness or Nonverbal Learning Disorder? Clinical Clues Help Differentiate Overlapping Symptoms and Syndromes. Current psychiatry.
146. Deliagin, M. (2014). Headache in children and adolescents. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.21518/2079-701x-2014-1-40-44
147. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
148. Deses, C. D. D. L. (2018). Alteraciones del sueño en personas adultas mayores. Revista de la Facultad de Medicina (México).
149. Devanand, D. P. (2004). Dysthymic Disorder In The Elderly. https://doi.org/10.1093/oso/9780195152746.003.0005
150. Devi, D. K. S. (2013). Study of the Differences in the Quality of Life and Disability among Patients with Schizophrenia and Bipolar Disorders and Assessment of the Burden among their Care Givers..
151. Dhanvij, M. A. S., Shingode, D., & Pathade, A. (2021). Case Report on Acute Transient Psychotic Disorder. Drugs and Cell Therapies in Hematology.
152. Dhingra, L., Ahmed, E., Shin, J. G., Scharaga, E., & Magun, M. (2015). Cognitive Effects and Sedation. Pain Medicine. https://doi.org/10.1111/pme.12912
153. Dhobe, S., Gujar, S., & Sc, M. (2021). Prevalence of Associated Factors of Depressive Symptoms among School Going Children’s. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v15i1.13470
154. Dias, I. M., Maia, I. D., Mello, L. M. R. D., Leite, I. C. G., & Leite, F. P. P. (2014). Evaluation of correlation among sleep bruxism and depression levels, chronic pain and nonspecific physical symptoms according to axis II of the Research Diagnostic Criteria/Temporomandibular disorders. RSBO Revista Sul-Brasileira de Odontologia.
155. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
156. Dieterich, C. A., Snyder, N. D., & Villani, C. J. (2016). A legal study of children with emotional disturbance and mental health needs and implications for practice.. The Journal of Law of Education.
157. DiLossi, J., & Harrison, M. (2023). Understanding Eating Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781009186865.004
158. Dilsaver, S. C., & Coffman, J. A. (1988). Seasonal depression.. PubMed.
159. DiMartini, A. (2007). Natural history of alcohol use disorders in liver transplant patients. Liver Transplantation. https://doi.org/10.1002/lt.21342
160. Dobrea, C., Dell’Osso, B., Carlotta, M., Cremaschi, L., Arici, C., Benatti, B., & Carlo, A. D. (2012). Neuroimaging Data in Bipolar Disorder: An Updated View. InTech eBooks. https://doi.org/10.5772/24566
161. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
162. Domínguez, M. R., Burgos, L. M., & Bergink, V. (2020). Perinatal Mood and Anxiety Disorders. Obstetrics and gynecology.. https://doi.org/10.1002/9781119450047.ch16
163. Donsu, J. D. (2016). Simtom Depresi dan Diabetes Mellitus: sebuah Comorbidity. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.22146/bpsi.11943
164. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
165. Drechsler, R., Walitza, S., & Werling, A. M. (2014). Klinische Praxis der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen und hyperkinetischen Störungen. PSYCH up2date. https://doi.org/10.1055/s-0034-1370208
166. Dreyer-Oren, S. E., Mitnaul, L., & Holtzheimer, P. E. (2018). Mood Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy25
167. Dua, T. (2021). Commentary on Mental Illness, it?s Causes and Prevention. Brain Disorders & Therapy.
168. Dudek, D., & Sobański, J. A. (2012). Mental disorders in somatic diseases: psychopathology and treatment. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.1539
169. Duval, F., Jautz-Duval, M. M., González, F., & Rabia, H. (2010). Bases neurobiológicas de vulnerabilidad psiquiátrica a lo largo de las etapas de la vida hormonal de la mujer. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272010000500005
170. Dziegielewski, S. F. (2014). Depressive Disorders. https://doi.org/10.1002/9781394260577.ch7
171. Dziegielewski, S. F. (2014). Quick References. https://doi.org/10.1002/9781394260577.bapp01
172. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
173. D’Souza, R. S., & Hooten, W. M. (2019). Somatic Syndrome Disorders.
174. Egbert, A. M. (1993). 'The dwindles'. Failure to thrive in older patients.. PubMed.
175. Eizaguirre, A. E. (2007). Impulsividad en la bulimia nerviosa y psicoterapia dinámica.. Cuadernos de terapia familiar.
176. Eizaguirre, M. Á. V., & Aróstegui, J. A. I. (2014). Alcance y limitaciones del tratamiento farmacológico del Trastorno por Déficit de Atención e Hiperactividad en niños y adolescentes y Guías de Práctica Clínica: una revisión bibliográfica. Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352014000100004
177. Elsayed, M., Negm, E., Gahr, M., & Schönfeldt‐Lecuona, C. (2023). Autoimmune polyglandular syndrome type 2 and recurrent depression. Annals of Medicine and Surgery. https://doi.org/10.1097/ms9.0000000000000235
178. Emmett, S. R., Hill, N. A., & Dajas‐Bailador, F. (2019). Psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199694938.003.0018
179. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
180. Eriksson, M. (2012). Beteendemässiga och fysiologiska effekter av stress hos häst.
181. Escobedo, A. D. Á. (2012). Influencia del estrés y depresión prenatal en el desarrollo del niño. Revista Peruana de Pediatría. https://doi.org/10.61651/rped.2012v65n3p158-169
182. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
183. Evi, E., Wiguna, T., & Malik, K. (2021). KOMORBIDITAS GANGGUAN TIDUR PADA ANAK DENGAN GANGGUAN PEMUSATAN PERHATIAN DAN HIPERAKTIVTAS. Jurnal Muara Medika dan Psikologi Klinis. https://doi.org/10.24912/jmmpk.v1i1.12086
184. Evren, C., & Dalbudak, E. (2009). Relationship of Personality Trait Impulsivity with Clinical Variables in Male Alcohol-Dependent Inpatients. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology.
185. Fachrudin, D. (2018). Skizofrenia Simpleks (sebuah studi kasus perspektif psikologi). Tunas Medika Jurnal Kedokteran & Kesehatan.
186. Faget-Agius, C., & Lançon, C. (2015). [Acute delirium in decompensated schizophrenia and bipolar disorder].. PubMed.
187. Falcão, F. A., Santos, A. L. D., Barbosa, D. C. B., & Santos, T. R. D. (2022). Responsabilidade civil no erro médico e dano moral. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.25
188. Fama, J. M., & Wilhelm, S. (2010). Obsessions. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0616
189. Fazel, M., Reed, R. V., & Goldring, L. (2012). Post-traumatic stress disorder. BMJ. https://doi.org/10.1136/bmj.e3790
190. Felgueiras, P., Martins, A., Miguel, A., & Almeida, N. (2021). Vascular depression – regarding a case report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.1146
191. Fernandes, C. E., Ferreira, J. A. D. S., Azevedo, L. H. D., Pellini, E. A. J., & Peixoto, S. V. (2004). Síndrome da tensão pré-menstrual – o estado atual dos conhecimentos. Arquivos Médicos do ABC.
192. Ferrara, P. (2014). Child abuse and neglect: psychiatric and neuro-biological consequences. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/1824-7288-40-s1-a32
193. Ferreira, K. V., & Melo, N. N. D. (2018). DEPRESSÃO EM IDOSOS: o papel do profissional farmacêutico. Psicologia e Saúde em Debate. https://doi.org/10.22289/2446-922x.v4n1a3
194. Fiar, Z., Hroudov, J., & Raboch, J. (2012). Neurotransmission in Mood Disorders. InTech eBooks. https://doi.org/10.5772/31831
195. Fink, M. (2010). Depressive Mood Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0009
196. Fink, M. (2010). Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0011
197. Finlayson, R. E. (1989). Recognition and management of dysthymic disorder.. PubMed.
198. Finsterer, J., & Zarrouk‐Mahjoub, S. (2013). Fatigue in Healthy and Diseased Individuals. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/1049909113494748
199. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
200. Fitzgerald, C., & Patten, S. B. (2008). Is Multiple Sclerosis Patient Depressed, Stressed, or Both? How to Sort through Overlapping Symptoms and Provide Appropriate Treatment. Current psychiatry.
201. Forbes, F. (2010). Improving recognition and management of ADHD.. Practitioner.
202. Foroutan, H. R., Vadiee, I., Nabavizadeh, A., Rafiee, M., Imanieh, M. H., Asadipouya, A., & Pirastehfar, M. (2005). CIDP and Achalasia: Two manifestations of a Disease or Coincidental Association. Iranian journal of medical sciences.
203. Frean, J., Jong, G. D., & Albrecht, R. (2008). Imaginary bugs, real distress: delusional parasitosis.. PubMed.
204. Frodl, T. (2023). Adaptive and maladaptive emotion regulation in bipolar disorder. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13626
205. Frommann, I., Pukrop, R., Brinkmeyer, J., Bechdolf, A., Ruhrmann, S., Berning, J., Decker, P., Riedel, M., Möller, H., Wölwer, W., Gäebel, W., Klosterkötter, J., Maier, W., & Wagner, M. (2010). Neuropsychological Profiles in Different At-Risk States of Psychosis: Executive Control Impairment in the Early—and Additional Memory Dysfunction in the Late—Prodromal State. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbp155
206. Furi, L. M. (2014). BIPOLAR AFFECTIVE DISORDER AND MANIC EPISODE WITH PSYCHOTIC SYMPTOMS IN A 39 YEARS OLD MAN. Jurnal Agromedicine.
207. Galanopoulos, N., Kampakis, G., & Ladopoulou, K. (2007). [Fibromyalgia and chronic fatigue syndrome in children and adolescents].. PubMed.
208. Galima, S. V., Vogel, S. R., & Kowalski, A. W. (2020). Seasonal Affective Disorder: Common Questions and Answers..
209. Galvez-Sánchez, C. M., Coba, P. D. L., Duschek, S., & Paso, G. A. R. D. (2020). Fibromyalgia Symptoms Overview. https://doi.org/10.32545/encyclopedia202009.0002.v2
210. Ganasan, S. (2019). Managing depression in the primary care setting. Journal of Prescribing Practice. https://doi.org/10.12968/jprp.2019.1.8.388
211. Ganda, K. M. (2013). Psychiatric Conditions: Assessment of Disease States and Associated Dental Management Guidelines. https://doi.org/10.1002/9781119421450.ch52
212. Gao, Q., Ma, Y., & Yuan, Z. (2023). The causes of schizophrenia in adolescents. https://doi.org/10.1117/12.2669381
213. Garay, M. A., Richards, S., Mj, M. U., & Luguercho, C. (2007). [Psychotic major depressive episode: target symptoms in males and females].. PubMed.
214. García-Medall, J., & López, E. A. (2016). Perfil psicolingüístico y trastornos de comportamiento en un adulto con síndrome de Williams. Moenia: Revista lucense de lingüistica & literatura.
215. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
216. Garza-Treviño, E. S. (1988). El manejo de urgencia de los cuadros psicóticos agudos. Salud Mental.
217. Gałecki, P., Florkowski, A., Zboralski, K., Pietras, T., Szemraj, J., & Talarowska, M. (2010). Psychiatryczne i Psychologiczne Powikłania Zespołu Obturacyjnego Bezdechu Sennego. Advances in respiratory medicine. https://doi.org/10.5603/arm.27684
218. Geenen, R., & Jacobs, J. W. G. (2001). Fibromyalgia: diagnosis, pathogenesis, and treatment. Current Opinion in Anaesthesiology. https://doi.org/10.1097/00001503-200110000-00012
219. Gehlawat, P., & Kumar, G. V. (2020). A narrative review of major depressive disorder in children and adolescents. Archives of Depression and Anxiety. https://doi.org/10.17352/2455-5460.000046
220. Geller, E., Ritvo, E., Freeman, B. J., & Yuwiler, A. (1982). Preliminary Observations on the Effect of Fenfluramine on Blood Serotonin and Symptoms in Three Autistic Boys. New England Journal of Medicine. https://doi.org/10.1056/nejm198207153070307
221. Ghaisani, N. (2018). Potensi Ketamin Dosis Rendah untuk Penderita Depresi Berat. JIMKI Jurnal Ilmiah Mahasiswa Kedokteran Indonesia.
222. Giacobbe, P., & Flint, A. J. (2007). Pharmacological treatment of poststroke pathological laughing and crying. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.0737
223. Giacomo, E. D., Moretti, F., Colmegna, F., & Clerici, M. (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
224. Giannakopoulos, G., Marini, E., Charitaki, S., Belivanaki, M., Salavou, V., Liakopoulou, M., & Kolaitis, G. (2013). Mental health of adolescents with type I diabetes: A case report. Health. https://doi.org/10.4236/health.2013.58172
225. Gilchrist, R. H., & Arnold, L. E. (2008). Long-term Efficacy of ADHD Pharmacotherapy in Children. Psychiatric Annals. https://doi.org/10.3928/00485713-20080101-03
226. Glasper, E. A., McEwing, G., & Richardson, J. M. (2011). Chapter 13 Mental health problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199547197.003.0075
227. Gleason, M. M., & Thompson, L. A. (2022). Depression and Anxiety Disorder in Children and Adolescents. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2022.0052
228. Gold, M. S. (1981). Diagnosis of Depression in the 1980s. JAMA. https://doi.org/10.1001/jama.1981.03310400044029
229. Gold, M. S. (1981). Diagnosis of depression in the 1980s. JAMA. https://doi.org/10.1001/jama.245.15.1562
230. Golden, C. J., & Golden, Z. L. (2004). Traumatic Brain Injury. Routledge eBooks. https://doi.org/10.4324/9780203336960-19
231. Golubtsova, L. I., & Vasil'chenko, G. S. (1988). [Sexual disorders in women with slowly progressing schizophrenia].. PubMed.
232. González, A. (2005). Fisiopatología y diagnóstico de la anorexia nerviosa y la bulimia.
233. González, C., Betés, M., López‐Muñoz, F., & Martín, J. D. D. M. (2011). Aportaciones de la psicofarmacología al tratamiento de los trastornos de la personalidad (II) = Contributions of psychopharmacology for the treatment of personality disorders (II: grupos farmacológicos empleados en el tratamiento de los trastornos de personalidad = pharmacological groups employed in the treatment of the disorders of personality /. Edupsykhé Revista de Psicología y Educación. https://doi.org/10.57087/edupsykhe.v10i2.3852
234. González, R. M., Quesada, H. S., & Sancho, L. V. (2010). Episodio mixto secundario al uso de fluoxetina en una paciente con un transtorno afectivo bipolar no diagnosticado. Revista Médica de Costa Rica y Centroamérica.
235. González, S. M. B., Campoy, A. T., Carballeda, J. M., Pastorelli, R. V., & Vallejo, J. V. G. (2011). ¿Manía vs psicosis tóxica vs trastornos de conducta? A propósito de un caso.. Psiquiatria.com.
236. Goodwin, G. M. (2011). Bipolar disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)73887-1
237. Goodyer, I., Herbert, J., Tamplin, A. K., & Altham, P. M. E. (2000). Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.177.6.499
238. Gordon, M., & Melvin, G. (2014). Prescribing for depressed adolescents: Office decision-making in the face of limited research evidence. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.12517
239. Granger, C. E., & Shelly, M. P. (1996). Stressing out, or outing stress?. European Journal of Anaesthesiology. https://doi.org/10.1097/00003643-199611000-00001
240. Greydanus, D. E., Calles, J. L., & Patel, D. R. (2008). Anxiety disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544705.007
241. Grieco, J. A., Pulsifer, M. B., Seligsohn, K., Skotko, B. G., & Schwartz, A. (2015). Down syndrome: Cognitive and behavioral functioning across the lifespan. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.31439
242. Griswold, K., Regno, P. A. D., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed.
243. Gruber, G., Saletu‐Zyhlarz, G., Anderer, P., Metka, M., Huber, J. C., Grätzhofer, E., & Saletu, B. (2007). Insomnia During Menopause. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-115-4_18
244. Grunze, H., & Born, C. (2020). The Impact of Subsyndromal Bipolar Symptoms on Patient’s Functionality and Quality of Life. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2020.00510
245. Grunze, H., Forsthoff, A., & Born, C. (2009). Polypharmazie in der Behandlung bipolarer Störungen. https://doi.org/10.1007/978-3-211-79826-3_3
246. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
247. Gupta, J., & Gaurkar, S. (2022). Migraine: An Underestimated Neurological Condition Affecting Billions. Cureus. https://doi.org/10.7759/cureus.28347
248. Gupta, K., & Mamidi, P. (2018). Deva grahonmada: Interictal behavior syndrome of temporal lobe epilepsy?/obsessive-compulsive disorder with mania?. International Journal of Yoga - Philosophy Psychology and Parapsychology. https://doi.org/10.4103/ijny.ijoyppp_24_17
249. Gupta, K., & Mamidi, P. (2022). Madonmada of Bhela samhita. Journal of Applied Consciousness Studies. https://doi.org/10.4103/ijoyppp.ijoyppp_16_21
250. Gupta, K., Parimal, B. S., & Patel, A. K. (2023). Mindfulness-Based Cognitive Therapy for Coping with Premenstrual Syndrome Distress. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-6684-5088-8.ch010
251. Gusmão, C. M. D., Maski, K., & Urion, D. K. (2014). Kleine-Levin Syndrome with Rapid Cycling - Case Report and Review of the Literature (P5.294). Neurology. https://doi.org/10.1212/wnl.82.10_supplement.p5.294
252. Guthrie, M., Zubatsky, M., & Smith, C. W. (2015). Family Stress and Counseling. Family Medicine. https://doi.org/10.1007/978-1-4939-0779-3_30-1
253. Haass, M., & Albus, C. (2014). Psychosoziale Faktoren bei Herzinsuffizienz: Mehr als eine Komorbidität?. Kardiologie up2date. https://doi.org/10.1055/s-0034-1365137
254. Hall, S. W. (2011). Idiopathic Environmental Intolerances. SpringerReference. https://doi.org/10.1007/springerreference_44303
255. Halvorsen, H. T., Hammer, S. K., Nystrøm, V., & Leonardsen, A. L. (2019). Delirium hos intuberte intensivpasienter. iNSPIRA. https://doi.org/10.23865/inspira.v14.2784
256. Hamed, S. A. (2014). Diabetes mellitus and the brain : special emphasis on cognitive function : review. The South African journal of diabetes & vascular disease.
257. Hammett, E., Fernandez-Carbonell, C., Crayne, C. B., Boneparth, A., Cron, R. Q., & Radhakrishna, S. M. (2020). Adolescent Sjogren’s syndrome presenting as psychosis: a case series. Pediatric Rheumatology. https://doi.org/10.1186/s12969-020-0412-8
258. Harding, S. (2005). Continuing Professional Development Managing delirium in older people.
259. Harrison, M. J. (1996). Clinical Skills in Neurology.
260. Hartanto, H., Hartono, B., & Nathawira, K. M. (2022). Sikap Berdiri Lama Dalam Menimbulkan Nyeri Punggung Bawah. Jurnal MedScientiae. https://doi.org/10.36452/jmedscientiae.v1i2.2661
261. Hassan, M. S., Sidow, N. O., & Mohamed, N. A. (2022). Transient global amnesia: Uncommon diagnosis of exclusion. Clinical Case Reports. https://doi.org/10.1002/ccr3.6533
262. Hatcher-Kay, C., & King, C. A. (2003). Depression and Suicide. Pediatrics in Review. https://doi.org/10.1542/pir.24-11-363
263. Hatcher-Kay, C., & King, C. A. (2003). Depression and Suicide. Pediatrics in Review. https://doi.org/10.1542/pir.24.11.363
264. Hauser, G., Tkalčić, M., Pletikosić, S., Sinčić, B. M., & Štimac, D. (2010). Can duration and severity of chronic bowel disease influence patients' psychosocial functioning?.
265. Hauser, G., Tkalčić, M., Pletikosić, S., Sinčić, B. M., & Štimac, D. (2011). Can duration and severity of chronic bowel disease influence patients' psychosocial functioning?.
266. Hautzinger, M. (1993). Depressionen. Verhaltenstherapie. https://doi.org/10.1007/978-3-662-22591-2_63
267. Hawkes, M. A., & Hocker, S. E. (2021). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0057
268. Hegeman, J. M. (2016). Appearance of depression in later life.
269. Helgesen, J. (2019). Lithium’s impact on proinflammatory cytokines in patients withbipolar disorder, schizophrenia and major depressive disorder:a systematic literature review..
270. Henkin, R. I., & Abdelmeguid, M. (2020). Smell Loss and Onset of Phantosmia are Critical Aspects of Head Injury Cognition. The FASEB Journal. https://doi.org/10.1096/fasebj.2020.34.s1.02320
271. Henna, E., Salesse, M. T., & Santos, M. M. D. (2018). Prevalência de transtorno mental comum e transtorno de personalidade em pacientes com diabetes mellitus tipo 1 atendidos no ambulatório do Conjunto Hospitalar de Sorocaba-SP. DOAJ (DOAJ: Directory of Open Access Journals).
272. Hensley, P. L., & Clayton, P. J. (2013). Why the Bereavement Exclusion Was Introduced in <i>DSM-III</i>. Psychiatric Annals. https://doi.org/10.3928/00485713-20130605-04
273. Herman, H., Ardani, I. G. A. I., Aryani, L. N. A., Windiani, I. G. A. T., Adnyana, I. G. N. S., & Setiawati, Y. (2022). Signs and symptoms of depression in children and adolescents with type 1 diabetes mellitus. International journal of health & medical sciences. https://doi.org/10.21744/ijhms.v5n1.1861
274. Hernández, Y. D. C. S. (2016). Alteraciones estructurales de las regiones cerebrales sexuales tras empleo de paroxetina versus agomelatina. https://doi.org/10.14201/gredos.129703
275. Herpertz, S. C., & Saß, H. (2000). Emotional deficiency and psychopathy. Behavioral Sciences & the Law. https://doi.org/10.1002/1099-0798(200010)18:5<567::aid-bsl410>3.0.co;2-8
276. Hidayat, L. S., & Kristiana, I. F. (2023). Religiosity and Mental Health: A Case Study. Proceedings of International Conference on Psychological Studies (ICPsyche). https://doi.org/10.58959/icpsyche.v4i1.59
277. Hirschfeld, R. M. A., Calabrese, J. R., Frye, M. A., Lavori, P. W., Sachs, G., Thase, M. E., & Wagner, K. D. (2007). Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.. PubMed.
278. Homans, J., & Nelson, K. J. (2016). Psychoticism Due to Personality Disorders or Stress-Related Phenomena. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199378067.003.0006
279. Hosztafi, S. (2011). [Heroin addiction].. PubMed.
280. House, J. S. (1987). Chronic stress and chronic disease in life and work: Conceptual and methodological issues. Work & Stress. https://doi.org/10.1080/02678378708258494
281. Huan-hua, S. (2013). Advance of Functional Dyspepsia Treatment. Medical Recapitulate.
282. Huda, A. S. (2019). Social factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0013
283. Huda, A. S. (2019). Spectrums of health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0009
284. Huprich, S. K. (2010). Schizoid Personality Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0819
285. Hvolby, A., Jørgensen, J., & Bilenberg, N. (2005). [Sleeping disorders can imitate attention deficit/hyperactivity disorder].. PubMed.
286. Iliev, B., & Pavlovska, I. (2021). Analysis of Clinical Features of Patients with Depressive Disorder. Journal of Health Medicine and Nursing. https://doi.org/10.7176/jhmn/92-01
287. Ilin, V., & Vygovskiy, E. (2016). THE HYPOTHESIS OF THE INTERDEPENDENCE OF THE INCIDENCE OF MEDICAL PROFESSIONALS AND THE SYNDROME OF PROFESSIONAL-PSYCHOLOGICAL DISADAPTATION. Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук. https://doi.org/10.12737/23732
288. Imboden, C., Christian, I., & Christian, C. (2020). Sports Psychiatry: Exercise and postpartum depression. Swiss Sports & Exercise Medicine. https://doi.org/10.34045/sems/2020/43
289. Impey, B., Gordon, R. P., & Baldwin, D. S. (2020). Anxiety disorders, post-traumatic stress disorder, and obsessive–compulsive disorder. Medicine. https://doi.org/10.1016/j.mpmed.2020.08.005
290. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
291. Iorga, M., Stârcea, I. M., Munteanu, M., & Sztankovszky, L.-Z. (2014). PSYCHOLOGICAL AND SOCIAL PROBLEMS OF CHILDREN WITH CHRONIC KIDNEY DISEASE.
292. Ishizuka, K., Shikino, K., Li, Y., Yokokawa, D., Tsukamoto, T., Yanagita, Y., Kojima, J., Yamashita, S., Noda, K., Uehara, T., & Ikusaka, M. (2023). The differential diagnosis of medical and psychogenic disease in primary care. Journal of General and Family Medicine. https://doi.org/10.1002/jgf2.661
293. Itani, R., Soubra, L., Karout, S., Rahme, D., Karout, L., & Khojah, H. M. J. (2022). Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates. Korean Journal of Family Medicine. https://doi.org/10.4082/kjfm.21.0103
294. Ivada, P. F., Ardani, I. G. A. I., Lesmana, C. B. J., Windiani, I. G. A. T., Adnyana, I. G. A. N. S., & Fithriyah, I. (2022). Quality of life of pediatric patients experiencing organic depressive disorder with Juvenile Idiopathic Arthritis. International journal of health & medical sciences. https://doi.org/10.21744/ijhms.v5n4.1994
295. İbiloğlu, A. O., Atlı, A., Kaya, M. C., Baran, A. S., & Sır, A. (2016). Psychogenic Gait Disorder After a Stressful Life Event: Case Report. Turkiye Klinikleri Journal of Case Reports. https://doi.org/10.5336/caserep.2015-46732
296. Jaspers, J. P. C. (2003). Lumpers versus splitters. Journal of Psychosomatic Obstetrics & Gynecology. https://doi.org/10.3109/01674820309074684
297. Jefferson, J. W. (2001). Social Anxiety Disorder. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v03n0102
298. Jehan, S., Auguste, E., Zizi, F., Pandi‐Perumal, S. R., Gupta, R., Attarian, H., Jean-Louis, G., & McFarlane, S. I. (2016). Obstructive Sleep Apnea: Women's Perspective.. PubMed.
299. Jen, J. C. (2015). Familial Hemiplegic Migraine.
300. Ji, J. (2012). Distinguishing subclinical (subthreshold) depression from the residual symptoms of major depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.007
301. Jibson, M. D., Glick, I. D., & Tandon, R. (2004). Schizophrenia and Other Psychotic Disorders. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/foc.2.1.17
302. Jidhun, P., & Chitra, P. (2016). A Case Report on Childhood Dysthymia-Low Mood Triggers The End. International Journal of Nursing Education. https://doi.org/10.5958/0974-9357.2016.00079.9
303. Jiménez, M. T. L., Villalpando, M. I. B., Sotres, J. F. C., Guines, M., & Jaime, M. (2011). Funcionamiento familiar, creencias e inteligencia emocional en pacientes con trastorno obsesivo-compulsivo y sus familiares. Salud Mental.
304. Joshi, S., & Kapur, J. (2012). GABAA Receptor Plasticity during Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199746545.003.0041
305. Judge, A. C. D. E. (2004). SSRIs: Effective Treatment for Depression. Journal watch. https://doi.org/10.1056/wh200411030000009
306. Juruena, M. F. (2012). Understanding subthreshold depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.009
307. Júnior, M. A. C., Malta, A. D. M. M., Faria, J. G. D., Saldaña, E. G. A., Ilizarbe, R. E. J., Souza, N. M. D., Silva, S. A. D., Silva, L. S. R. D., Santos, P. R., Sakman, R., Ribeiro, A. R., & Vouillat, S. E. (2023). Anxiety in the elderly in the context of the COVID-19 pandemic. Contribuciones a las Ciencias Sociales. https://doi.org/10.55905/revconv.16n.11-234
308. Kadmaerubun, M. C., Sutejo, S., & Syafitri, E. N. (2016). HUBUNGAN KEMANDIRIAN ACTIVITY DAILY LIVING (ADL) DENGAN KUALITAS HIDUP PADA PASIEN SCHIZOPHRENIA DI POLIKLINIK JIWA RSJ GRHASIA DIY.
309. Kahn, D., & Chaplan, R. (2002). The “Good Enough” Mood Stabilizer: A Review of the Clinical Evidence. CNS Spectrums. https://doi.org/10.1017/s1092852900017594
310. Kamra, A., Bhatia, & Sapra, S. (2004). Self-injurious behavior in children: A review. Journal of Forensic Medicine.
311. Kane, J. M. (1996). Schizophrenia. New England Journal of Medicine. https://doi.org/10.1056/nejm199601043340109
312. Kanner, A. M., & Dunn, D. W. (2004). Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy. Journal of Child Neurology. https://doi.org/10.1177/088307380401900108
313. Kanyengo, C. W. (2009). Zambia: The challenge of informing blind and deaf clients.
314. Karaaslan, K., Gümüş, E., Gülcü, N., & Altunrende, B. (2008). Dirençli Jeneralize Status Epileptikusun Propofol ile Tedavisi (Olgu Sunumu). Duzce Medical Journal.
315. Katiri, R., Hall, D. A., & Kitterick, P. T. (2020). Developing an International Core Outcome Set for SSD Interventions. The Hearing Journal. https://doi.org/10.1097/01.hj.0000661612.83232.57
316. Katzman, M. A. (2021). The Diagnosis of Major Depressive Disorder is based on the Person's Reported Experiences and a Mental Status Examination. Journal of Aging and Geriatric Medicine.
317. Kayser, B., & Gremion, G. (2004). Chronic fatigue and loss of performance in endurance athletes: overtraining. Schweizerische Zeitschrift für Sportmedizin und Sporttraumatologie.
318. Kazi, S. E., & Anwar, A. (2022). Pseudobulbar Affect Presenting as Aggressive Behavior. Cureus. https://doi.org/10.7759/cureus.21978
319. Keck, P. E., Frye, M. A., & Thase, M. E. (2007). Bipolar Depression: <i>Best Practices for the Hospitalized Patient</i>. CNS Spectrums. https://doi.org/10.1017/s1092852900015844
320. Kellett, J. M. (1993). Long term care on the NHS: a vanishing prospect.. BMJ. https://doi.org/10.1136/bmj.306.6881.846
321. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
322. Kelly, M. M., & Phillips, K. A. (2023). Phenomenology and Epidemiology of Body Dysmorphic Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780190068752.013.3
323. Kelly, S. D. (2021). The Acute Stress Syndrome Stabilization Remote Individual (ASSYST-RI) for TeleMental Health Counseling After Adverse Experiences. Psychology and Behavioral Science International Journal. https://doi.org/10.19080/pbsij.2021.16.555932
324. Kennedy, S. H. (2008). Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.3/shkennedy
325. Ketch, T., Biaggioni, I., Robertson, R. M., & Robertson, D. (2002). Four Faces of Baroreflex Failure. Circulation. https://doi.org/10.1161/01.cir.0000017186.52382.f4
326. Ketterer, M. W., & Buckholtz, C. D. (1989). Somatization disorder.. PubMed.
327. Khaikin, Y., & Mercimek‐Andrews, S. (2016). STXBP1 Encephalopathy with Epilepsy.
328. Khan, A. Y., Kalia, R., Ide, G. D., & Ghavami, M. (2017). What Are Realistic Treatment Goals? Lingering Symptoms Require You to Evaluate Pharmacotherapy and Offer Psychosocial Interventions. Current psychiatry.
329. Khan, S. I. (2021). Loss of appetite.. Preventive Nutrition and Food Science.
330. Khanam, S. (2017). Impact of Stress on Physiology of Endocrine System and on Immune System: A Review. International Journal of Diabetes and Endocrinology. https://doi.org/10.11648/j.ijde.20170203.12
331. Khune, A. A., Rathod, H., Deshmukh, S. P., & Chede, S. B. (2023). Mental health, depressive disorder and its management: A review. GSC Biological and Pharmaceutical Sciences. https://doi.org/10.30574/gscbps.2023.25.2.0464
332. Kim, G.-M., Jeong, W., & Hwang, T. (2019). Depression and Gap between Perceived- and Self-Willingness-to-Pay for Labor in Community-Dwelling Full-Time Female Homemakers. Journal of Korean Neuropsychiatric Association. https://doi.org/10.4306/jknpa.2019.58.4.322
333. Kim, H. A., Bisdorff, A., Bronstein, A. M., Lempert, T., Rossi-Izquierdo, M., Staab, J. P., Strupp, M., & Kim, J. (2019). Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-190655
334. Kirkby, K. C. (2007). Recognising and Responding to Candidates' Health Needs. ACER Press eBooks.
335. Kivelä, S., & Pahkala, K. (1988). Clinician-Rated Symptoms and Signs of Depression in Aged Finns. International Journal of Social Psychiatry. https://doi.org/10.1177/002076408803400405
336. Knapen, J., Vancampfort, D., Schoubs, B., Probst, M.-T., Sienaert, P., Haake, P., Peuskens, J., & Pieters, G. (2009). Exercise for the Treatment of Depression. The Open Complementary Medicine Journal. https://doi.org/10.2174/1876391x00901010078
337. Ko, J. Y., Wolicki, S. B., Barfield, W. D., Patrick, S. W., Broussard, C. S., Yonkers, K. A., Naimon, R., & Iskander, J. (2017). CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. MMWR Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6609a2
338. Kocsis, J. H., & Brody, B. D. (2013). Chronic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.010
339. Kolla, B., & Hocker, S. E. (2021). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0045
340. Konstantakopoulos, G. (2019). Insight across mental disorders: A multifaceted metacognitive phenomenon. Psychiatriki. https://doi.org/10.22365/jpsych.2019.301.13
341. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
342. Koponen, H., Lepola, U., & Leìnonen, E. (1995). Recurrent brief depression: A review. Nordic Journal of Psychiatry. https://doi.org/10.3109/08039489509011882
343. Kopp, S., & Gillberg, C. (2022). [Symptoms, diagnostic process and outcome in girls and women with ADHD].. PubMed.
344. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
345. Kowatch, R. A. (2007). Risperidone's 2 New Pediatric Indications: Approval Supports Antipsychotic Use in Children with Schizophrenia or Bipolar Disorder. Current psychiatry.
346. Koychev, I., & Ebmeier, K. P. (2016). Anxiety in older adults often goes undiagnosed.. PubMed.
347. Kreek, M. J. (2011). Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonment. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2011.06152.x
348. Krystal, A. D., Edinger, J. D., & Wohlgemuth, W. K. (2013). Sleep and Circadian Rhythm Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt08
349. KS, M. C., Nagarajan., K., & Kanagarajan, A. (2023). Insomnia Management Clinical Trials by various Conventional Therapies – A Review. Research Journal of Pharmacy and Technology. https://doi.org/10.52711/0974-360x.2023.00985
350. Kumara, H., & Kumar, V. (2016). Impact of Cognitive Behavior Therapy on Anxiety and Depression in Adolescent Students. JOURNAL OF PSYCHOSOCIAL RESEARCH.
351. Lahey, B. B. (2021). Dimensions of Externalizing Problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197607909.003.0004
352. Laila, F. N., Algristian, H., & Azizah, N. (2023). Case Study : Prognosis of Recurrent Depressive Disorder with Somatic Symptoms. International Islamic Medical Journal. https://doi.org/10.33086/iimj.v5i1.4454
353. Laili, S. R. (2019). Asuhan Keperawatan Jiwa dengan Kasus Halusinasi Penglihatan di Wilayah Kerja UPTD Puskesmas Kecamatan Sananwetan Kota Blitar.
354. Lam, R. W. (2018). Associated clinical features. Depression. https://doi.org/10.1093/med/9780198804147.003.0005
355. Lam, R. W. (2018). Clinical features and diagnosis. Depression. https://doi.org/10.1093/med/9780198804147.003.0004
356. Lassal, R., Laurent, M., & Purper‐Ouakil, D. (2011). [Early signs of mental disorders in children aged 3-12 years].. PubMed.
357. Lawrie, S. M. (2010). Schizophrenia, bipolar disorder, obsessive–compulsive disorder, and personality disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260507
358. Lazaratou, H. (2013). [Attention-deficit hyperactivity disorder or bipolar disorder in childhood?].. PubMed.
359. Ledezma, C., Soto, K., & Suárez, M. I. (2015). Depresión en el adulto mayor en Costa Rica: un problema social. Revista Hispanoamericana de Ciencias de la Salud.
360. LEHMAN, M., Foster, C., & Keul, J. (1993). Overtraining in endurance athletes: a brief review. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/00005768-199307000-00015
361. Lejoyeux, M., & Adès, J. (1993). [Psychiatric emergencies in acute alcoholic intoxication].. PubMed.
362. Lembeck, M. A., Grønlund, C., Djurhuus, B. D., Lindelof, M., & Holm, E. (2021). The chronically dizzy patient. Ugeskrift for Læger.
363. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
364. Lewinsohn, P. M., Zeiss, A. M., Zeiss, R. A., & HALLER, R. (1977). ENDOGENEITY AND REACTIVITY AS ORTHOGONAL DIMENSIONS IN DEPRESSION. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-197705000-00003
365. Lewis, C. F. (2015). Anxiety disorders including post traumatic stress disorder (PTSD). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199360574.003.0035
366. Lečić-Toševski, D. M., Pejović-Milovančević, M., Popović-Deušić, S., & Šušić (2007). [Psychiatric aspects of sleep].. PubMed.
367. Li, K., & Loshak, H. (2019). Intravenous Ketamine for Adults with Treatment-Resistant Depression or Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines.
368. Li, X., & Li, S. X. (2022). Paediatric Insomnia. https://doi.org/10.1007/978-981-19-5791-8_6
369. Li, Y., Qian, Q., & Wang, Y. (2007). [Adult's outcome of attention deficit hyperactivity disorder and its predictive factors (review)]..
370. Lieb, K., Stoffers‐Winterling, J., & Dulz, B. (2014). Pharmakologische Behandlung von Borderline-Persönlichkeitsstörungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1627733
371. Loconte, S. (2019). Primary fibromyalgia syndrome: A new holistic approach [abstract]. Journal of Ozone Therapy. https://doi.org/10.7203/jo3t.3.4.2019.15526
372. Loitman, J. E., & Deshields, T. L. (2010). Psychiatric Palliative Care Issues. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-590-3_4
373. Luccarelli, J., McCoy, T. H., Yip, A. G., Seiner, S. J., & Henry, M. (2022). Borderline personality disorder traits are not associated with a differential change in global cognitive function during acute course ECT. Brain stimulation. https://doi.org/10.1016/j.brs.2022.04.006
374. Lucchesi, L. M., Pradella-Hallinan, M., Lucchesi, M., & Moraes, W. A. D. S. (2005). O sono em transtornos psiquiátricos. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462005000500006
375. Lucena, A. C. D. A., Lopes, E. D. A. N., Marinho, F. M. D. S., & Pelo, M. V. G. (2022). Fatores que influenciam para o desenvolvimento da depressão na gestação. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.1
376. Luijendijk, H. J. (2010). Vascular Heart and Brain Disease and Incident Late-Life Depression.
377. López-Ibor, J. J. (1990). The spectrum of mood disorders.. PubMed.
378. MacKinnon, D. F. (2015). Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch50
379. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
380. Macovei, A. L., Dobrin, I., Chiriță, V., Burlui, A., Dobrin, P.-R., & Rezuş, E. (2019). Chronic fatigue and psychiatric comorbidities in patients with rheumatic disorders. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2019.03.08
381. MacPherson, H. A. (2019). More than medication: The importance of family treatments for pediatric bipolar disorder. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30433
382. Madruga, M. L. L. H., Melo, G. B., Martins, J. M., Aranha, R. E. L. D. B., Marinho, J. C. R. L., Alves, N. T., Estudo, E., Revisão, U., & Literatura, D. (2018). Estudo Eletroencefalográfico De Indivíduos Com Dor Crônica Decorrente Da Fibromialgia: Uma Revisão Da Literatura. Scientific Research and Reviews. https://doi.org/10.28933/srr-2018-06-28100
383. Mahato, T. K., Ojha, S. K., Singh, V., & Parihar, S. P. S. (2021). Addiction withdrawal syndrome: Needs medications, education, counselling &amp; support. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2021.12.2.0573
384. Maj, M. (2023). Understanding depression beyond the “mind‐body” dichotomy. World Psychiatry. https://doi.org/10.1002/wps.21142
385. Majeske, M., Nistor, V., & Kellner, C. H. (2016). Late‐Life Psychosis. https://doi.org/10.1002/9781118654231.ch35
386. Malenfant, M., Tremblay, S., Laurin, D., & Lefèbvre, J. (2008). L'utilisation du citalopram pour traiter l'agitation et les symptômes psychotiques chez les patients souffrant de démence.
387. Malt, U. F. (1996). [Long-term treatment and prevention of depression].. PubMed.
388. Manakil, J. F. (2012). Depression and periodontal health.
389. Mantere, O., & Vuorilehto, M. (2015). [Recognition of mood disorders].. PubMed.
390. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
391. Maremmani, I., Pacini, M., & Maremmani, A. G. I. (2023). Chronic Psychosis in Dual Disorder Heroin Use Disorder Patients. https://doi.org/10.1007/978-3-031-30093-6_4
392. Maremmani, I., Pacini, M., Lamanna, F., Pani, P., Perugi, G., Deltito, J., Salloum, I. M., & Akiskal, H. S. (2010). Mood Stabilizers in the Treatment of Substance Use Disorders. CNS Spectrums. https://doi.org/10.1017/s1092852900027346
393. Markham, R. A., & Watts, S. (2005). Etiology of Depression in Children.. Journal of instructional psychology.
394. Martin, K. A. (2021). Miscellaneous Psychiatric Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0043
395. Martins, M. B., Boff, C., & Ávila, C. T. (2021). Desafios da avaliação neuropsicológica: depressão x declínio cognitivo na pessoa idosa / Neuropsychological assessment: depression versus cognitive decline in the elderly. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv4n5-408
396. Martínez, A. R., Argüelles, P. P., Cucurella, M. M., Llort, A. J., Camacho, J. A., & Plana, J. C. (2008). Manifestaciones neurológicas en el síndrome hemolítico urémico. Revista de Neurología. https://doi.org/10.33588/rn.4704.2008249
397. Martínez‐Salio, A., Soler-Algarra, S., Calvo-Garcia, I., & Sánchez-Martín, M. (2007). Síndrome de ingesta nocturna relacionada con el sueño con respuesta al topiramato. Revista de Neurología. https://doi.org/10.33588/rn.4505.2007188
398. María, A., Sancho, R., & Pita, B. L. (2005). Trastornos de ansiedad en la infancia y en la adolescencia.
399. Mateen, Y., Lally, J., & Bokhari, S. Q. (2022). Chronic, Unipolar, Treatment-Resistant Mania: A Case Report and Literature Review. BJPsych Open. https://doi.org/10.1192/bjo.2022.363
400. Mateus, L. A. S. (2022). Games violentos e sua relação com comportamento social das crianças. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.19
401. Mazet, P., Bouquerel, G., & Millier, C. L. (1981). [Psychological and psychiatric emergencies in child and adolescent. Specificity and diversity of the possible situations and responses (author's transl)].. PubMed.
402. Mc, M.-S. (1993). [Post-traumatic stress syndrome in children].. PubMed.
403. McArdle, P. (2004). Attention-deficit hyperactivity disorder and life-span development. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.184.6.468
404. McCullough, J. P. (2010). Cognitive Behavioral Analysis System of Psychotherapy. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0192
405. McFarlane, S. I. (2021). Editorial Note on Psychosis. Brain Disorders & Therapy. https://doi.org/10.35248/2168-975x.21.s2.e003
406. McFarlane, S. I. (2021). Subjective on Bipolar Disorders. Brain Disorders & Therapy.
407. McIntyre, R. S., & Calabrese, J. R. (2019). Bipolar depression: the clinical characteristics and unmet needs of a complex disorder. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2019.1636017
408. McMurran, M. (2012). Other Personality Disorders. https://doi.org/10.1002/9781118156391.ebcp002023
409. McPherson, S. (2004). Apathy in Alzheimer’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-661-4_44
410. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
411. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
412. Mehler‐Wex, C. (2012). Entwicklungspsychiatrische Aspekte depressiver Störungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628164
413. Mehta, P., & Rani, G. S. (2020). Identification and Early Intervention of Bipolar Disorder in Adolescence and Adults. International Journal of Engineering and Advanced Technology. https://doi.org/10.35940/ijeat.b3637.029320
414. Mellero, D. (2007). Ansiedade em situações de convívio social em idosos.
415. Mewes, R., & Rief, W. (2008). Somatoforme Störungen und Hypochondrie. Psychiatrie und Psychotherapie up2date. https://doi.org/10.1055/s-2007-986338
416. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
417. Meza, E. G. L., Téllez, F. C., Guevara, I. M. A., González-Aragón, M. D. C. F., & Calderón, L. Á. R. (2003). Estado epiléptico no convulsivo asociado a enfermedad de Lafora: presentación de dos casos. Revista de Neurología. https://doi.org/10.33588/rn.3710.2003290
418. Michael, D. M., Branford, D., & Barrett, M. J. (2015). Bipolar Affective Disorder. https://doi.org/10.1002/9781118897164.ch16
419. Miller, F. T., Abrams, T., Dulit, R., & Fyer, M. R. (1993). Psychotic Symptoms in Patients With Borderline Personality Disorder and Concurrent Axis I Disorder. Psychiatric Services. https://doi.org/10.1176/ps.44.1.59
420. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
421. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Clinical case report on bipolar affective disorder, mania. IP Journal of Paediatrics and Nursing Science. https://doi.org/10.18231/j.ijpns.2022.007
422. Mirawati, D. K. (2018). Managing antiepileptic drug, Starting, Changing and Stopping AED’s.
423. Mitchell, P. B., Goodwin, G. M., Johnson, G. F., & Hirschfeld, R. M. A. (2008). Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2007.00559.x
424. Mitropoulos, G. B. (2021). Being psychotic is not necessarily being ill: Psychotic continuum and the relevance of lacanian psychoanalytic approach. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2127
425. Mizukami, K. (2013). [Alzheimer's disease and depression].. PubMed.
426. MM, B., Islam, S., Nh, S., Rahman, M., & Bari, M. (2016). None. MOJ Orthopedics & Rheumatology. https://doi.org/10.15406/mojor.4.1
427. Mn, Z. (1991). [Effect of environmental factors on the development of clinical polymorphism of familial schizophrenia].. PubMed.
428. Moch, S. (2011). Dysthymia: more than "minor".
429. Moch, S. (2011). Dysthymia: more than “minor” depression. South African Pharmaceutical Journal.
430. Molière, F. (2014). Comorbidités psychiatriques et résistance thérapeutique. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.052
431. Mondimore, F. M., & Kelly, P. (2011). Borderline Personality Disorder: New Reasons for Hope.
432. Montalto, S. A. (2021). Intrapartum Asphyxia and Its Sequelae. Cambridge University Press eBooks. https://doi.org/10.1017/9781108863049.061
433. Montgomery, S., Bebbington, P., Cowen, P. J., Deakin, J., Freeling, P., Hallström, C., Katona, C., King, D. S., Leonard, B., Levine, S., Phanjoo, A. L., Peet, M., Thompson, C. M., & Thompson, C. M. (1993). Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881193007001041
434. Moore, D. P., & Puri, B. K. (2012). Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience 3E.
435. Morin, C. (2009). [Sense of personal identity and focal brain lesions].. PubMed. https://doi.org/10.1684/pnv.2009.0156
436. Moro‐de‐Casillas, M. L., & Riley, D. E. (2012). Insomnia in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_17
437. Morylowska-Topolska, J., Ziemiński, R., Molas, A., Gajewski, J., Flis, M., Stelmach, E., & Karakuła‐Juchnowicz, H. (2016). Schizophrenia and anorexia nervosa – reciprocal relationships. A literature review. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/63514
438. Moshki, M., & Kharazmi, A. (2015). Application of the PRECEDE Model to Understanding Postnatal Depression.. PubMed.
439. Mossaheb, N., Schloegelhofer, M., Schaefer, M., Fusar‐Poli, P., Smesny, S., McGorry, P. D., Berger, G., & Amminger, G. P. (2012). Long-Chain Omega-3 Fatty Acids and Psychotic Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-215-5_9
440. Moukaddam, N., Cavazos, E., Nazario, M., Murtaza, S. T., & Shah, A. A. (2019). Depression and Its Impact on Adolescents. Psychiatric Annals. https://doi.org/10.3928/00485713-20190506-01
441. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
442. Mucci, V., Sussetto, M., Ranieri, M., Cavuscens, S., Fornos, A. P., & Guinand, N. (2019). [The Mal de Débarquement Syndrome].. PubMed.
443. Mueller‐Pfeiffer, C., & Wittmann, L. (2013). Preliminary Investigation of the Reliability and Validity of the German Version of the State Scale of Dissociation (SSD). Journal of Traumatic Stress Disorders & Treatment. https://doi.org/10.4172/2324-8947.1000106
444. Munir, S., & Takov, V. (2021). Generalized Anxiety Disorder. StatPearls.
445. Munir, S., Takov, V., & Coletti, V. A. (2021). Generalized Anxiety Disorder (Nursing).
446. Murakami, M., & Matsuno, T. (2010). Musculoskeletal Chronic Pain and Psychosocial Stress. Journal of Nihon University Medical Association. https://doi.org/10.4264/numa.69.183
447. Murata, C. (2020). Behavioral Problems in Children. Springer series on epidemiology and public health. https://doi.org/10.1007/978-981-15-1831-7_2
448. Murty, V. L., Baid, G. C., Sharma, S., Singh, S. K., Lath, V., & Jena, P. (2023). Obstructive Sleep Apnea: A Prosthodontist’s Viewpoint. Scholars Journal of Dental Sciences. https://doi.org/10.36347/sjds.2023.v10i05.005
449. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
450. Nafiaa, H., Benchikhi, L., & Ouanass, A. (2022). Morphological Abnormalities in Schizophrenia: Systematic Review. SAS Journal of Medicine. https://doi.org/10.36347/sasjm.2022.v08i05.005
451. Nanagas, M. T. (2011). Bipolar Disorders. Pediatrics in Review. https://doi.org/10.1542/pir.32.11.502
452. Narang, T., Garima, & Singh, S. M. (2016). Psychosexual disorders and dermatologists. Indian Dermatology Online Journal. https://doi.org/10.4103/2229-5178.182349
453. Nasrallah, H. A. (2009). Diagnosis 2.0 Are Mental Illnesses Diseases, Disorders, or Syndromes? A Major Challenge for the DSM-V Committees as They Revise the Diagnostic "Bible" of Psychiatric Disorders Is to Determine Whether Mental Illnesses Are Diseases, Disorders, or Syndromes. Current psychiatry.
454. Nasrallah, H. A. (2014). Borderline Personality Disorder Is a Heritable Brain Disease. Current psychiatry.
455. Nava, G. M. (2018). Depression: From Sorrow to Melancholia. Scholarly Journal of Psychology and Behavioral Sciences. https://doi.org/10.32474/sjpbs.2018.01.000106
456. Ninaprilia, Z., & Rohmani, C. F. (2015). Gangguan Mood Episode Depresi Sedang. Jurnal Medula.
457. Noctor, E., Kennedy, K., & Corby, C. S. (2020). Manic-like presentation with an organic aetiology. Irish Journal of Psychological Medicine. https://doi.org/10.1017/ipm.2020.76
458. Nopianta, R., Iskandar, R. J., & Hoendarto, G. (2019). PENERAPAN SENSOR GAS PADA PERANCANGAN APLIKASI PENDEKTEKSI ALKOHOL PADA NAFAS MANUSIA.
459. Novák, M. (2010). S27-04 - Sleep Disorders, Mental Health and Quality of Life. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70094-8
460. Ntchana, A. (2022). A Case of Brief Psychotic Disorder: An Unintended Consequence of COVID-19 Virus. American Journal of Biomedical Science & Research. https://doi.org/10.34297/ajbsr.2022.16.002239
461. Ntchana, A. (2022). A Case of Brief Psychotic Disorder: An Unintended Consequence of COVID-19 Virus. Psychology & Psychological Research International Journal. https://doi.org/10.23880/pprij-16000300
462. Oates, L. (2010). Complementary medicines for anxiety. Australian pharmacist.
463. Ojha, A., & Kumar, D. (2021). Psychological Factors in Fibromyalgia and Chronic Fatigue Syndrome: Implications in Counseling. https://doi.org/10.56173/bjcp.2021.1102
464. Oliveira, S., Canha, J., & Pereira, S. P. (2013). 2362 – Is it a prodrome of psychosis? Or is it naanxious disorder? A case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)77202-x
465. Olmedo, A., & Rolando, M. (2015). Informe psicológico pericial: situación de violencia intrafamiliar, “maltrato física, psicológica y sexual”, grado de afectación psicológico..
466. Olmos-López, A., Ibarra-Aguilar, J., Cornelio-Nieto, J. O., Ocaña-Hernández, L. A., Márquez-Amaya, M. A., Luna-López, N. A., Reséndiz-Aparicio, J. C., & Rodríguez‐Leyva, I. (2019). Clinical guideline: status epilepticus in children and adults. DELETED. https://doi.org/10.24875/rmn.m19000031
467. Orihuela-Carpio, F. S., Magno-Muro, P., & Cruzado, L. (2022). Depresión psicótica secundaria a hipertiroidismo y desenlace letal por tormenta tirotóxica: a propósito de un caso.. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v85i2.4232
468. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
469. Osterman, J. E., Erdos, B. Z., Oldham, M., & Ivkovic, A. (2010). Antidepressant Treatments in PTSD. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-435-7_7
470. O’Dwyer, A.-M., & Campion, M. (2022). Anxiety and obsessional disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198867135.003.0008
471. Pablo, G. S. D. (2018). Mental Capacity and Decision Making in Bipolar Disorder. Peer Reviewed Journal of Forensic & Genetic Sciences. https://doi.org/10.32474/prjfgs.2018.03.000152
472. Pachana, N. A., Laidlaw, K., Ceglowski, J., Dios, L. V. D., & Depp, C. A. (2014). Psychosis in Older Adults. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199663170.013.041
473. PADMAWATI, N. N., Ardani, I. G. A. I., Ariyani, A., Ariani, P., & Purnamasidhi, ‪. A. W. (2021). Psychopharmaceutical Therapy and Supportive Psychotherapy for COVID-19 Patients with Depression. International Journal of Medical Reviews and Case Reports. https://doi.org/10.5455/ijmrcr.covid-19-psychopharmaceutical-therapy-172-1608192666
474. Padmos, R. C. (2009). Inflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases.
475. Paidi, G., Jean, M., Oduwole, A., Gautam, N., Kapoor, K., & Paidi, R. (2022). Chronic Unexplained Vomiting: A Case Report on Psychogenic Vomiting. Cureus. https://doi.org/10.7759/cureus.25959
476. Palmer, B. A. (2021). Personality and Illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0042
477. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
478. Pan, E., Algül, A., Ebrinç, S., Başoğlu, C., Semiz, Ü., Ateş, M. A., Şenol, M. G., & Çetin, M. (2010). P01-293 - Psychiatric mis-diagnoses and escitolopram treatment of mood and anxiety disorders in myasthenia gravis: a case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70501-0
479. Paradela, E. M. P. (2011). Depressão em idosos. Revista Hospital Universitário Pedro Ernesto (TÍTULO NÃO-CORRENTE). https://doi.org/10.12957/rhupe.2011.8850
480. Pary, R., Lippmann, S., & Tobias, C. R. (1988). Depression and Alcoholism: Clinical Considerations in Management. Southern Medical Journal. https://doi.org/10.1097/00007611-198812000-00016
481. Patel, A., & Patel, K. (2016). A Case of Childhood Onset Obsessive Compulsive Disorder Presented as School Refusal for a Year. International Journal of Indian Psychology. https://doi.org/10.25215/0401.012
482. Patti, L., & Gupta, M. (2019). Change In Mental Status. StatPearls.
483. Paulin, L. F. R. D. S., Reis, E. F. D., & Rodrigues, E. P. (2008). Síndrome de descontinuação dos antidepressivos.
484. Pavlović, J., Joković, S., & Hadživuković, N. (2016). The impact of dementia on the nutritional status in elderly people. PONS - medicinski casopis. https://doi.org/10.5937/pomc13-12338
485. Paykel, E. S. (2008). Partial remission, residual symptoms, and relapse in depression. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.4/espaykel
486. Pechnick, R. N., Cunningham, K. A., & Danovitch, I. (2014). Hallucinogen-Related Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg51
487. Pedroso, A. P. F., Tomasetti, C. S., Coelho, C. I., Pinho, E. C. D. A., & Oliani, S. M. (2018). Stress em renais crônicos: treino de relaxamento amenizando a sessão de hemodiálise. Revista Terra & Cultura: Cadernos de Ensino e Pesquisa.
488. Peitl, M. V., Prološčić, J., Zelić, S. B., Skarpa-Usmiani, I., & Peitl, V. (2011). Symptoms of agitated depression and/or akathisia.. PubMed.
489. Peixoto, C., Rêgo, D. C., Bicho, M., Coelho, J. M., & Medeiros, H. (2021). Psychiatric symptoms in huntington’s disease. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.682
490. Pereira, J. A. (2021). Teenager with paranoia and hallucinations preceded by a decline in academic and social functioning. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197577479.003.0006
491. Perrin, J. M., Gnanasekaran, S. K., & Delahaye, J. (2012). Psychological Aspects of Chronic Health Conditions. Pediatrics in Review. https://doi.org/10.1542/pir.33.3.99
492. Perrino, C. D. D. (2009). Prevalencia de síntomas afectivos en una cohorte de pacientes con trastorno bipolar: Un estudio de seguimiento prospectivo hasta 18 meses.
493. Peterson, E., Yao, C., Sule, S., & Finkel, J. C. (2020). Juvenile fibromyalgia: A call for diagnostic refinement, a case report. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-78745/v1
494. Peveler, R. (2002). ABC of psychological medicine: Depression in medical patients. BMJ. https://doi.org/10.1136/bmj.325.7356.149
495. Peña, D. A., Pérez, M. L., & Pinzón, L. F. C. (2014). Línea de investigación psicología clínica y de la salud..
496. Phan, S. (2013). Primary or secondary? What came first and how to treat?. Mental Health Clinician. https://doi.org/10.9740/mhc.n178411
497. Phillips, K. A. (2014). Body Dysmorphic Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg22
498. Pich, E. M., Heidbreder, C., Mugnaini, M., & Teneggi, V. (2003). Molecular and Behavioral Aspects of Nicotine Dependence and Reward. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_16
499. Pichler, W. J., & Pichler, C. E. (2009). DRESS (Drug Rash with Eosinophilia and Systemic Symptoms). Allergologie. https://doi.org/10.5414/alp32365
500. Pigarova, E., & Rozhinskaya, L. Y. (2010). Sindrom khronicheskoy ustalosti: sovremennye predstavleniya ob etiologii. Obesity and metabolism. https://doi.org/10.14341/2071-8713-4977
501. Piwuna, C. G., Makput, D. M., & Wakil, M. A. (2015). Persistent delusional disorder in a 32 year old male. Highland Medical Research Journal.
502. Pizov, A. V. (2022). Peculiarities of insomnia in men and women at different age periods. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/2079-701x-2022-16-21-112-118
503. Plotkin, K. E. (2007). Insomnia Caused by Medical Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-042-7_15
504. Plum, F. (1989). Dementia. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4899-6768-8_17
505. Podkrajsek, K., Strajnar, A., Tansek, M. P., Battelino, T., & Grošelj, U. (2018). Hyperinsulinism-hyperammonemia syndrome in an infant with seizures. Balkan Journal of Medical Genetics. https://doi.org/10.2478/bjmg-2018-0014
506. Post, R. M. (2002). Introduction: Emotion and Psychopathology. https://doi.org/10.1093/oso/9780195126013.003.0048
507. Potart, C., Pellerin, J., & Pinquier, C. (2003). [Hysteria and aging].. PubMed.
508. Pottash, A. C. (1981). Depression and Abnormal Endocrinologic Tests-Reply. JAMA. https://doi.org/10.1001/jama.1981.03320180024019
509. Potvin, O., Hudon, C., Grenier, S., & Préville, M. (2010). Non-essential symptoms of depression and cognitive impairment no dementia (CIND) in community-dwelling elders without dysphoria or anhedonia. International Psychogeriatrics. https://doi.org/10.1017/s1041610210001419
510. Prager, L. M. (2009). Depression and Suicide in Children and Adolescents. Pediatrics in Review. https://doi.org/10.1542/pir.30.6.199
511. Prater, C., & Zylstra, R. G. (2002). Autism: a medical primer.. PubMed.
512. Praško, J., Raszka, M., & Pastucha, P. (2009). Dissociative Disorders - Clinical Manifestation and Management. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70376-1
513. Presečki, P., Filipčić, I., Arbanas, G., & Mimica, N. (2014). Neurocognitive disorders in DSM-5.
514. Prieto, I., & González, L. L. (2004). Es la distimia tardía un trastorno diferente a la distimia precoz. Psiquis: Revista de psiquiatría, psicología médica y psicosomática.
515. Prvčić, I., Zec, M. R., & Barišić, I. (2008). Psychological aspects of learning disabilities. Paediatria Croatica. https://doi.org/10.13112/pc.925
516. Putri, P. R. N. E. (2020). Asuhan keperawatan diabetes mellitus tipe 2 dengan ulkus diabetik pada ny. J di upt puskesmas rawat inap sungai pakning.
517. Qureshi, M. A., & Wasti, S. A. (2014). Lay-off Survivor Sickness Syndrome (Investigating the Lasting Impact on Performance of Survivors in the Context of Age and Gender in Private Sector Organizations of Pakistan). International Journal of Human Resource Studies. https://doi.org/10.5296/ijhrs.v4i3.6078
518. Rabi-Žikić, T., Nedić, A., Žarkov, M., Slankamenac, P., Dobrenov, D., & Živanović, Ž. (2009). Poststroke depression: Diagnosis of depression, phenomenology and specificity of depressive symptoms. Medicinski pregled. https://doi.org/10.2298/mpns0904148r
519. Rabia, K., & Khoo, E. M. (2008). A mentally retarded patient with schizophrenia.. DOAJ (DOAJ: Directory of Open Access Journals).
520. Rades, M., & Wulandari, A. J. (2016). Skizoafektif Tipe Campuran. Jurnal Medula.
521. Rahmani, M., Ahmadi, S., & Moghaddam, H. H. (2011). Serotonin Syndrome Following Single Ingestion of High Dose.
522. Rakofsky, J. J. (2016). RELAPSE: Answers to Why a Patient Is Having a New Mood Episode. Current psychiatry.
523. Ramakrishnan, N., Bansal, A., & Ponnish, A. S. (2022). Practical approach to sleep disordered breathing. Indian Journal of Respiratory Care. https://doi.org/10.5005/jp-journals-11010-02205
524. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
525. Rao, T. S., & Kumar, M. A. (2008). Agenda for specialty section in addiction medicine. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.44741
526. Rapkin, A. J., & Mikacich, J. (2007). Clinical evaluation and management. CRC Press eBooks. https://doi.org/10.3109/9781435628168-19
527. Rascol, O., Payoux, P., Ory, F., Ferreira, J. J., Brefel‐Courbon, C., & Montastruc, J. (2003). Limitations of current Parkinson's disease therapy. Annals of Neurology. https://doi.org/10.1002/ana.10513
528. Rathee, S. (2019). Psychosocial management of bipolar affective disorder. International Journal of Indian Psychology. https://doi.org/10.25215/0704.048
529. Rayfield, A., Thomas, C., & Borovicka, M. C. (2014). Management of behavioral and psychological symptoms of dementia: The role of mood stabilizers. Mental Health Clinician. https://doi.org/10.9740/mhc.n204493
530. Reddy, M. S. (2014). Irritability as a Criterion in Diagnosis of Child and Adolescent Bipolar Disorder: Thorny Road Ahead. Indian Journal of Psychological Medicine. https://doi.org/10.4103/0253-7176.130954
531. Reddy, S., Elsayem, A., & Talukdar, R. (2005). Palliative Care. CRC Press eBooks. https://doi.org/10.1201/b14119-59
532. Reichenberg, L. W., & Seligman, L. (2016). Bipolar and Related Disorders. https://doi.org/10.1002/9781394259465.ch4
533. Reichenberg, L. W., & Seligman, L. (2016). Dissociative Disorders. https://doi.org/10.1002/9781394259465.ch9
534. Resch, M. (2010). The psychological factors affecting athletic performance. Orvosi Hetilap. https://doi.org/10.1556/oh.2010.28890
535. Retamal, P., Vandeputte, F., & Massman, T. (2023). Factores de Protección en el Trastorno Afectivo Bipolar: Una Revisión Narrativa de la Literatura. Revista médica de Chile. https://doi.org/10.4067/s0034-98872023000600764
536. Reuber, M., Schachter, S. C., Elger, C. E., & Altrup, U. (2009). Conditions Associated With Epilepsy. https://doi.org/10.1093/oso/9780195379532.003.0005
537. Riaz, Y., & Sergi, C. (2021). Feeding Disability In Children.
538. Rico, B. (2012). Finding a druggable target for schizophrenia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1209389109
539. Riley, M. A., Ahmed, S., & Locke, A. (2016). Common Questions About Oppositional Defiant Disorder.. PubMed.
540. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
541. Rizwana, S. R. S., Josna, T. J. T., & G.V.Nagaraju, G. (2019). CASE STUDY ON DEPRESSION. International Journal of Indigenous Herbs and Drugs.
542. Rodrigo, M. L., Monge, M. P., Fominaya, M. P., Oliver, A. O., Guerra, M. T., Montero, C. G., & Font, V. R. (2022). Two of us live in this body. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.2256
543. Rodrigo, M. V. L., Oliver, A. O., Monge, M. P., Fons, V. R., & Cantalejo, Y. D. (2023). Stigma of mental illness in the gypsy ethnic group. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1438
544. Rodrigues, F. D. A. A. (2022). WHAT HAPPENS IN THE BRAIN OF A PERSON WITH DISORDER. International Journal of Health Science. https://doi.org/10.22533/at.ed.1592442202087
545. Rodríguez, M. J. M., Barceló, J. S., Millares, M. V., Alfonso, A. P., Guzmán, P. D. U., Barbazán, C. A., & Mahía, M. D. C. G. (2013). Es la edad de inicio del trastorno bipolar un buen marcador de dos entidades distintas. Revista gallega de psiquiatría y neurociencias.
546. Rogers, N. L., & Kloss, J. D. (2004). Medical Conditions and Diseases. CRC Press eBooks. https://doi.org/10.3109/9780203998007-6
547. Rolin, D., Whelan, J., & Montano, C. B. (2020). Is it depression or is it bipolar depression?. Journal of the American Association of Nurse Practitioners. https://doi.org/10.1097/jxx.0000000000000499
548. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
549. Roncero, C., & Casas, M. (2004). Trastornos de ansiedad en patología dual.
550. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
551. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
552. Rudolf, G. A. E. (2000). Diagnostische und therapeutische Maßnahmen bei einzelnen schizophrenen Syndromen und in bestimmten krankheitsbedingten Situationen. Deutscher Universitätsverlag eBooks. https://doi.org/10.1007/978-3-322-85177-2_7
553. Ruiz-Padrino, N., & Andrés-Tauler, J. M. (2014). Episodio hipomaniaco secundario al tratamiento con claritromicina en paciente adolescente. Revista de Psiquiatría Infanto-Juvenil.
554. Ruiz‐Rizzo, A. L., & Restrepo, F. L. (2008). Memoria explícita en el trastorno depresivo mayor. IATREIA. https://doi.org/10.17533/udea.iatreia.4479
555. Rus, S. S., Solis, M., Rodríguez, L. S., & Suárez-Gómez, M. (2021). Depressive disorder in childhood: The importance of an early diagnosis for a functional recovery. Specific symptoms and treatment in an 8-years old patient with depression. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.891
556. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
557. Sahu, S., Chaudhury, S., & Saldanha, D. (2021). Quality of Life and Marital adjustment in spouses of schizophrenia patients.
558. Sakakibara, R., & Katsuragawa, S. (2022). Depression and LUT (Psychogenic LUTS). https://doi.org/10.1007/978-981-16-7939-1_78-1
559. Salokangas, R. K. R., & McGlashan, T. H. (2008). Early detection and intervention of psychosis. A review. Nordic Journal of Psychiatry. https://doi.org/10.1080/08039480801984008
560. Santeusanio, F. (2012). Quadri internistici ed endocrinologici connessi alla disabilitŕ grave. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003010
561. Santucci, K. T. T., Miranda, A. H., Oliveira, A. J. R., & Vieira, A. F. D. B. (2022). Psicologia organizacional e do trabalho e a humanização no contexto hospitalar. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.15
562. Sapkota, N. K. (2017). Depression led pitting edema: A rarest case presentation.. PubMed.
563. sarah, S. (2022). MANFAAT BUNGA LAVENDER BAGI PENDERITA INSOMNIA DAN CARA PENANGANAN PENYAKIT INSOMNIA. https://doi.org/10.31219/osf.io/chd37
564. sarah, S. (2022). MANFAAT BUNGA LAVENDER BAGI PENDERITA INSOMNIA DAN CARA PENANGANAN PENYAKIT. https://doi.org/10.31219/osf.io/4za3q
565. Sari, M. N., Sulyaman, S., Sulistiono, A., & Ramadhian, M. R. (2016). Gangguan Kepribadian dan Perilaku Akibat Penyakit, Kerusakan, dan Disfungsi Otak pada Pria Usia 45 Tahun. Jurnal Medula.
566. Sari, R. A. (2020). Literature Review: Depresi Postpartum. Jurnal Kesehatan. https://doi.org/10.26630/jk.v11i1.1586
567. Sarkar, S. (2016). Psychiatric Polypharmacy, Etiology and Potential Consequences. Current Psychopharmacologye. https://doi.org/10.2174/2211556005666160916124719
568. Sarkar, S., & Dinesh, M. (2023). The threshold problem of impairment criteria in psychiatric diagnosis. Journal of SAARC Psychiatric Federation. https://doi.org/10.4103/jspf.jspf_12_23
569. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
570. Schenck, C. H. (2003). Assessment and Management of Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2475
571. Scherbaum, N., & Specka, M. (2014). Komorbide psychische Störungen bei Opiatabhängigen. Suchttherapie. https://doi.org/10.1055/s-0033-1363240
572. Schildkrout, B. (2011). Characteristics That Make Somatic Diseases Difficult to Detect. https://doi.org/10.1002/9781118083598.ch3
573. Schildkrout, B. (2011). Specific Mental Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch9
574. Schildkrout, B. (2011). Specific Physical Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch7
575. Schmidt, N., & Witt, K. (2014). Konzept der hypodopaminergen und hyperdopaminergen Verhaltensstörungen bei Parkinson-Patienten. Aktuelle Neurologie. https://doi.org/10.1055/s-0034-1370239
576. Schneider, G. (2020). Diagnostik von psychischen Faktoren bei chronischem Pruritus. Der Hautarzt. https://doi.org/10.1007/s00105-020-04596-1
577. Schneiderman, N., Ironson, G., & Siegel, S. D. (2004). Stress and Health: Psychological, Behavioral, and Biological Determinants. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev.clinpsy.1.102803.144141
578. Schneier, F. R., Bruce, L. C., & Heimberg, R. G. (2014). Social Anxiety Disorder (Social Phobia). American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg18
579. Scott, J. (1988). Chronic Depression. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.153.3.287
580. Scott, J. (2000). Treatment of Chronic Depression. New England Journal of Medicine. https://doi.org/10.1056/nejm200005183422010
581. Scotton, W. J., Hill, L. J., Williams, A., & Barnes, N. M. (2019). Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International Journal of Tryptophan Research. https://doi.org/10.1177/1178646919873925
582. Sehra, A., Shetty, S. K., & HP, S. (2022). Effect of Siddharthaka Agada Arka Pratimarsha Nasya in Kaphaja Unmada (Depressive Disorders). Journal of Ayurveda and Integrated Medical Sciences. https://doi.org/10.21760/jaims.7.10.13
583. Seifert, B., Lukáš, K., Charvátová, E., Vojtíšková, J., Koudelka, T., Hep, A., Bureš, J., Jirásek, V., & Dítě, P. (2007). Lower dyspeptic syndrome. Recommended diagnostic and therapeutic procedures for general practitioners 2006.
584. Seifert, K. (2014). Aversive Childhood Experiences, Without Appropriate Interventions, Lead to Life Course Violent and Criminal Behavior. Journal of Psychology & Clinical Psychiatry. https://doi.org/10.15406/jpcpy.2014.01.00020
585. Seikowski, K., Harth, W., & Hermes, B. (2008). Lifestyle Drugs in Old Age – A Mini-Review. Gerontology. https://doi.org/10.1159/000173697
586. Seiner, S., Baldessarini, R. J., Camprodon, J. A., Dougherty, D. D., Givon, L., DeVido, J., & Alpert, J. E. (2021). Psychopharmacology and Neurotherapeutics. Cambridge University Press eBooks. https://doi.org/10.1017/9780511846403.015
587. Sejdić, E., Malandraki, G. A., & Coyle, J. L. (2018). Computational Deglutition: Using Signal- and Image-Processing Methods to Understand Swallowing and Associated Disorders [Life Sciences]. IEEE Signal Processing Magazine. https://doi.org/10.1109/msp.2018.2875863
588. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
589. Seligman, L. D., Swedish, E. F., & Ollendick, T. H. (2014). Anxiety Disorders in Children. https://doi.org/10.1002/9781394259359.ch7
590. Sengupta, R., Roy, S., & Bhattacharya, M. (2019). STUDY OF GENE-ENVIRONMENT CAUSES OF MAJOR DEPRESSIVE DISORDER TO STATISTICALLY DEFINE THE MOST COMMON CAUSE BEHIND IT.. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/8804
591. Setiawan, I. M. A. (2015). GANGGUAN HIPOKONDRIK: SEBUAH LAPORAN KASUS. DOAJ (DOAJ: Directory of Open Access Journals).
592. Shahada, Z., Khalalyli, N., Allahham, L., & Kudsi, M. (2023). Acute psychosis as the presenting manifestation of lupus: case reports. International Journal of Surgery Global Health. https://doi.org/10.1097/gh9.0000000000000384
593. Sharabyani, S. M. (2016). MENTAL DISORDER AND THEIR TREATMENT. Journal of Fundamental and Applied Sciences. https://doi.org/10.4314/jfas.v8i3s.388
594. Sharma, S., Kishore, J., & Gupta, V. (2014). Adolescent Mental Health: From Normalcy to Illness. Indian Journal of Youth and Adolescent Health.
595. Sharpe, M. (2010). Chronic fatigue syndrome (postviral fatigue syndrome, neurasthenia, and myalgic encephalomyelitis). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260504
596. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
597. Shejekar, S., Nemlekar, S., & Srivastava, A. (2019). Organic mood disorder: Sequelae of small vessel disease. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_357_18
598. Shende, V., & Patel, F. R. (2014). AGMATINE AMELIORATES SOCIAL ISOLATION INDUCED OBSESSIVE-COMPULSIVE BEHAVIOR IN MICE.
599. Shin, J. E., Park, K. S., & Nam, K. (2019). Chronic Functional Constipation. Korean Journal of Gastroenterology. https://doi.org/10.4166/kjg.2019.73.2.92
600. Shirley, E. A., Hudspeth, L. J., & Maynard, J. R. (2018). Managing Sports-related Concussions From Time of Injury Through Return to Play. Journal of the American Academy of Orthopaedic Surgeons. https://doi.org/10.5435/jaaos-d-16-00684
601. Shprecher, D., & Mehta, L. (2010). The syndrome of delayed post-hypoxic  leukoencephalopathy.. PubMed.
602. Sikter, A. (2022). Chronic psychic stress can cause metabolic syndrome through mild hypercapnia.. PubMed.
603. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
604. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
605. Sinha, R., & Singh, S. (2021). Clinical and Electroencephalogram Correlation of Self-Limited Epilepsy with Autonomic Seizures. Indian Pediatrics Case Reports. https://doi.org/10.4103/ipcares.ipcares_287_21
606. Sinha, S., Moss, A. J., & Calkins, H. (2007). The etiology of sudden death. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544828.014
607. Skjelstad, D. V., Holte, A., & Malt, U. F. (2012). Putative early manifestations of bipolar II disorder emerge later in the initial prodrome than manifestations hypothesized to be unrelated: an exploratory study. Early Intervention in Psychiatry. https://doi.org/10.1111/j.1751-7893.2012.00348.x
608. Slater, R. J., & Yearwood, A. C. (1980). Facts, Faith, and Hope. AJN American Journal of Nursing. https://doi.org/10.2307/3470065
609. Smith, S. S. (2019). Insomnia and Clinical Sleep Disturbance in Later Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.419
610. Soler, J., Targa, I., & Alemany, T. G. (2016). A major depression or a bipolar disorder type 2? A cased-focussed psycopathological and psychophysiological challenge for a resident. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1200
611. Solmi, M., Bortolato, B., Veronese, N., Stubbs, B., Herrmann, N., & Carvalho, A. F. (2019). Pharmacological Interventions for Cognitive Dysfunction in Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0018
612. Song, S. Y., Pei, Y., Tippett, S. R., Lamichhane, D., Zallek, C. M., & Hsiao‐Wecksler, E. T. (2018). Validation of a Wearable Position, Velocity, and Resistance Meter for Assessing Spasticity and Rigidity. 2017 Design of Medical Devices Conference. https://doi.org/10.1115/dmd2018-6906
613. Souza, C. D., Miranda, A. H., Venturin, M. D. D. D. L., & Marino, M. F. B. (2022). Bruxismo na psicanálise, quando a dor não se cala. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.9
614. Soysal, P., & Işık, A. T. (2014). Hypoactive Delirium Caused by Pulmonary Embolus in an Elderly Adult. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12720
615. Spanagel, R., Tran, B. X., Reyes‐Gibby, C. C., DeBeck, K., Ibrahim, F., & Bonevski, B. (2016). Advances in Drug Addiction.
616. Spasova, R. G. (2019). ETHICAL CONSIDERATIONS IN THE INTEGRATED CARE FOR PATIENTS WITH CHRONIC PAIN. Knowledge International Journal.
617. Sprigings, D. (2018). Delirium (acute confusional state). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199568741.003.0041
618. Sriramoju, M., Keerthi, V. P., Alumdri, D. B., & Akula, S. (2014). Evaluation of antidepressant activity of ethanolic and aqueous extract of Solanum tuberosum peel. Journal of Comprehensive Pharmacy. https://doi.org/10.37483/jcp.2014.1503
619. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
620. Steinberg, J. (1981). Depression and abnormal endocrinologic tests. JAMA. https://doi.org/10.1001/jama.246.18.2032
621. Steinert, C., Heim, N., & Leichsenring, F. (2021). Procrastination, Perfectionism, and Other Work-Related Mental Problems: Prevalence, Types, Assessment, and Treatment—A Scoping Review. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.736776
622. Stewart, D. E. (2012). Depression During Pregnancy. Obstetrical & Gynecological Survey. https://doi.org/10.1097/ogx.0b013e31824b6f88
623. Stewart, S. M. (2013). Depression. The Encyclopedia of Cross‐Cultural Psychology. https://doi.org/10.1002/9781118339893.wbeccp158
624. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
625. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
626. Stoppe, G. (2019). Depression in Old Age. Socijalna psihijatrija. https://doi.org/10.24869/spsih.2019.261
627. Strain, J. J., Klipstein, K., & Newcorn, J. H. (2008). Adjustment Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch81
628. Straszek, S. P., Licht, R. W., Nielsen, R. E., & Vinberg, M. (2022). [Bipolar depression, a challenge diagnostic and treatmentwise].. Research Portal Denmark.
629. Strosahl, K. D. (2022). ACT con el paciente multiproblemático. ABA España eBooks. https://doi.org/10.26741/978-84-09-43990-4_09
630. Stubbe, D. (2007). Child and adolescent psychiatry : a practical guide. Lippincott Williams & Wilkins eBooks.
631. Stumpf, B. P., & Rocha, F. L. (2010). Síndrome de Diógenes. Jornal Brasileiro de Psiquiatria. https://doi.org/10.1590/s0047-20852010000200012
632. Stănescu, A. M. A., Simionescu, A. A., Grăjdeanu, I. V., & Florea, M. (2021). Preventive intervention for depression in children, adolescents and adults. Romanian Journal of Medical Practice. https://doi.org/10.37897/rjmp.2021.s4.13
633. Sumiyoshi, T., Matsuoka, T., & Kurachi, M. (2012). Role for Pituitary Neuropeptides in Social Behavior Disturbances of Schizophrenia. InTech eBooks. https://doi.org/10.5772/52326
634. Summers, C. B. (2007). Cognitive-Behavior Group Therapy in Residential Treatment. https://doi.org/10.4324/9780203941157-16
635. Suárez, A. L. Á. (2022). Evaluación del efecto antidepresivo del secretoma derivado de células madre mesenquimáticas precondicionadas en un modelo animal de trastorno depresivo mayor. https://doi.org/10.52611/11447/6617
636. Swain, S. K. (2023). Persistent Postural-perceptual Dizziness: A Review. Apollo Medicine. https://doi.org/10.4103/am.am_144_23
637. Swann, A. C. (2009). Pharmacologic Mood Destabilization: <i>Case Vignettes</i>. CNS Spectrums. https://doi.org/10.1017/s1092852900003898
638. Syaukat, A. (2021). Hypochondriasis: A Literature Review. Scientia Psychiatrica. https://doi.org/10.37275/scipsy.v3i1.85
639. Szabó, P., & Szászi, B. (2021). [Body dysmorphic disorder: One Hundred Years of Solitude].. Psychiatria Hungarica.
640. Szerman, N., Ferre, F., Basurte-Villamor, I., Vega, P., Mesías, B., Marín-Navarrete, R., & Arango, C. (2020). Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience Perspective. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2020.589155
641. Szkodny, L. E., Jacobson, N. C., Llera, S. J., & Newman, M. G. (2014). Generalized Anxiety Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg19
642. Szyguła‐Jurkiewicz, B., Szymik, M., Mrozowska, B., Schmidt, B., & Michalak, A. (2011). Psychologiczne uwarunkowania i konsekwencje ostrego zawału serca. Leki psychotropowe u chorych po ostrym zawale serca. Choroby Serca i Naczyń.
643. Sánchez, L. C., Cardona, A., cordoba, S., Silva, A. V., Ruiz, A. C., Ibáñez‐Pinilla, M., Pérez-Olmos, I., & Flórez, J. (2010). Experiencias de estigma en personas con enfermedad mental y su impacto en la autoestima en Colombia. reponame:Repositorio Institucional EdocUR.
644. Sánchez-Pérez, M., Roncero, C., Gálvez-Ortiz, V., Cardoner, N., Crespo-Blanco, J. M., Navarro-Odriozola, V., García–Parés, G., Eucb, G., & Psiquiatría, S. D. (2011). Use of bubropion in elderly patients.
645. Sürig, L., & Purper‐Ouakil, D. (2016). Trouble Déficit de l’Attention/Hyperactivité (TDAH), estime de soi et impact des traitements. Médecine thérapeutique / Pédiatrie. https://doi.org/10.1684/mtp.2016.0610
646. Tan, S. N., & Lim, E. C. (2020). Intractable Restless Legs Syndrome – Look for Other Causes. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.18177
647. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
648. Tariq, F. (2012). Premature Ejaculation Re-Visited: Definition and Contemporary Management Approaches. InTech eBooks. https://doi.org/10.5772/25670
649. Tatsuzawa, Y., Ono, Y., Takahashi, T., Yoshino, A., & Nomura, S. (2011). Case of isolated adrenocorticotropic hormone deficiency mimicking major depressive disorder. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2011.02207.x
650. Tedyanto, E. H., Adnyana, I. M. O., & Widyadharma, I. P. E. (2023). Tension-type Headache and Migraine as Manifestations of Chronic Post-Traumatic Headache. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v50i2.528
651. Terman, M., & Terman, J. S. (2013). Chronotherapeutics. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.026
652. Terrazas, E. E., López, A. G., Hernando, M., & Barquero, M. J. G. (2011). "Depresión": Imprecisión diagnóstica y terapéutica. Importantes consecuencias en la práctica clínica. Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352011000300005
653. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
654. Thyer, B. A., & Wodarski, J. S. (2007). Social work in mental health : an evidence-based approach. Wiley eBooks.
655. Toda, K. (2022). How long is the appropriate duration to determine that the hormone therapy is ineffective in menopause?. Authorea (Authorea). https://doi.org/10.22541/au.166239725.50426965/v1
656. Todorović, S. (2016). Socijalno medicinske karakteristike i razlike između alkoholičara sa periodičnim i kontinuiranim pijenjem / Social and Medical Characteristics and Differences Between Alcoholics With Periodic and Continuous Drinking. SESTRINSKI ŽURNAL. https://doi.org/10.7251/sez0116005t
657. Tolani, S. (2021). Impact of Major Depressive Disorder on Psychiatric Comorbidity of Females in Low Income Countries. Clinical and Experimental Psychology. https://doi.org/10.35248/2471-2701.21.7.244
658. Tollefson, G. D., Souêtre, E., Thomander, L., & Potvin, J. H. (1993). Comorbid anxious signs and symptoms in major depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00013
659. Tomasetti, C. (2014). Spatial and temporal patterns of postsynaptic genes and proteins expression by multiple receptors targeting agents: unraveling the impact of multitargeting approach on dopamine-glutamate mediated synaptic plasticity.
660. Tondo, L., Albert, M. J., Koukopoulos, A. E., Baethge, C., & Baldessarini, R. J. (2005). Bipolar Disorder. Humana Press eBooks. https://doi.org/10.1385/1-59259-856-0:205
661. Toone, B. (2004). Attention deficit hyperactivity disorder in adulthood. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2002.002022
662. Torpy, J. M. (2010). Delirium. JAMA. https://doi.org/10.1001/jama.304.7.814
663. Touloumis, C. (2021). Treatment resistant depression: Challenges and therapeutic choices. Psychiatriki. https://doi.org/10.22365/jpsych.2021.047
664. Townsend, M. C. (2004). Nursing diagnoses in psychiatric nursing : care plans and psychotropic medications. F.A. Davis Co. eBooks.
665. Treanor, M., & Roemer, L. (2010). Generalized Anxiety Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0379
666. Trill, M. D. (2012). Psychological aspects of depression in cancer patients: an update. Annals of Oncology. https://doi.org/10.1093/annonc/mds350
667. Tsimmerman, Y. S., & Tsimmerman, I. Y. (2021). Depressive syndrome in gastroenterology. Herald of Pancreatic Club. https://doi.org/10.33149/vkp.2021.04.07
668. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
669. Tuovinen, S., Lahti‐Pulkkinen, M., Girchenko, P., Heinonen, K., Lahti, J., Reynolds, R. M., Hämäläinen, E., Villa, P., Kajantie, E., Laivuori, H., & Räikkönen, K. (2020). Maternal antenatal stress and mental and behavioral disorders in their children. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2020.09.063
670. Ullah, M. (2023). DIAGNOSIS OF FIBROMYALGIA IN HEALTH PRACTICE. Northwest journal of medical sciences.. https://doi.org/10.69723/njms.02.04.0370
671. Usón, J. R. V., & Gracia, A. C. I. (2009). Trastorno por déficit de atención/hiperactividad en adultos. Revista de Neurología. https://doi.org/10.33588/rn.48s02.2009017
672. Valente, S. M. (1996). Diagnosis and Treatment of Panic Disorder and Generalized Anxiety in Primary Care. The Nurse Practitioner. https://doi.org/10.1097/00006205-199608000-00004
673. Valente, S. M. (2015). Evaluating and Managing Insomnia: Non-pharmacological Treatments. Journal of Sleep Disorders & Therapy. https://doi.org/10.4172/2167-0277.1000189
674. Vanin, J. R. (2008). Brief Psychiatric History and Mental Status Examination. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-263-2_2
675. VANVALKENBURG, C., Lilienfeld, S. O., & Akiskal, H. S. (1987). The impact of familial personality disorder and alcoholism on the clinical features of depression. Psychiatry and Psychobiology. https://doi.org/10.1017/s0767399x00004284
676. Varghese, R., John, D., & Arun, M. (2007). A case of primary hypersomnia. Annals of Indian Academy of Neurology. https://doi.org/10.4103/0972-2327.31489
677. Vasiliu, O., & Vasile, D. (2016). Risk factors and quality of life in late-life depressive disorders. Romanian Journal of Military Medicine. https://doi.org/10.55453/rjmm.2016.119.3.5
678. Veale, D. (2004). Body dysmorphic disorder. Postgraduate Medical Journal. https://doi.org/10.1136/pmj.2003.015289
679. Veen, D. C. V. D. (2021). Anxiety in late-life depression. https://doi.org/10.33612/diss.179793202
680. Velasco-Rey, M. C., Sánchez-Muñoz, M., Lopez, M., Trujillo-Borrego, A., & Sánchez-Bonome, L. (2012). Psychotic depression induced by Obstructive Sleep Apnoea Syndrome (OSAS): a case reported.. PubMed.
681. Ventegodt, S., & Merrick, J. (2005). Clinical Holistic Medicine: The Patient with Multiple Diseases. The Scientific World JOURNAL. https://doi.org/10.1100/tsw.2005.42
682. Vicente, J. F. M. (2014). Estado epiléptico refractario en el entorno de la terapia intensiva. Medicina Crítica.
683. Vigueras, P., Vigueras, J. P., Meca, R. L., Fernández, P. R., Retuerto, B. M., González, J. G., & Gaspar, J. C. (2011). La crisis económica y las urgencias hospitalarias generales y psiquiátricas. Puesta al día en urgencias, emergencias y catástrofes.
684. Villamar, S., & Lorena, J. (2019). Factores psicosociales y depresión geriátrica en un paciente.
685. Vlašić, K. M. (2016). Sestrinska skrb za bolesnike oboljele od depresivnog poremećaja.
686. Vonk, R. (2016). The influence of genes and environment on the development of bipolar disorder: A twin study.
687. Voon, V., Thomsen, T., Miyasaki, J. M., Souza, M. D., Shafro, A., Fox, S. H., Duff‐Canning, S., Lang, A. E., & Zurowski, M. (2007). Factors Associated With Dopaminergic Drug–Related Pathological Gambling in Parkinson Disease. Archives of Neurology. https://doi.org/10.1001/archneur.64.2.212
688. Vulser, H., & Lebeau, G. (2019). Post-Traumatic Stress Disorder Following Intraoperative Awareness. Neuromethods. https://doi.org/10.1007/978-1-4939-9891-3_5
689. Wadhwa, R., & Khandare, M. (2014). Stress Management through Yoga. Global Journal of Human-Social Science.
690. Wahyuni, A., & Fr, C. (2020). Gangguan Mental Organik e.c. Epilepsi pada Laki-Laki Usia 17 Tahun : Laporan Kasus. Jurnal Medula.
691. Wahyuningsih, S., Nurun, N., Ainul, A., Rendra, R., & Dwiki, D. (2020). Relaksasi Nafas Dalam Terhadap Tingkat Kecemasan Pada Lansia Yang Menderita Hipertensi Di RT 03 RW 09 Kelurahan Slipi Palmerah Jakarta Barat. JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM). https://doi.org/10.33024/jkpm.v3i2.3194
692. Wakefield, J. C. (2015). DSM-5 substance use disorder: how conceptual missteps weakened the foundations of the addictive disorders field. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12446
693. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
694. Walterscheid, B., Eshak, N., & Nugent, K. (2021). Altered mental status in a patient with psychiatric history: Medication noncompliance or medical etiology?. Journal of Investigative Medicine.
695. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
696. Wardani, I. A. K., & Nuaba, I. G. A. (2023). Consultation liaison psychiatry (CLP) approach to esophagus stenosis patients with depression. International Journal of Health Sciences. https://doi.org/10.53730/ijhs.v7n2.14466
697. Wardani, I. A. K., & TIASTININGSIH, N. N. (2023). GANGGUAN TIDUR PADA PENDERITA GANGGUAN AFEKTIF BIPOLAR. Jurnal Hasil Penelitian dan Pengembangan (JHPP). https://doi.org/10.61116/jhpp.v1i3.158
698. Weber, P., Vepřeková, B., & Kadaňka, Z. (2009). Psychiatrická problematika v intenzivní medicíně vyššího věku.
699. Wei, L., Benhui, S., Lanping, J., & Xiaolin, T. (2014). The Impact of Health Education or Health of the Victims of the Earthquake in Disaster Area. Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research. https://doi.org/10.2991/asshm-14.2014.7
700. Weisholtz, D. S., & Dworetzky, B. A. (2014). Epilepsy and Psychosis.
701. West, A. E., & Pavuluri, M. N. (2009). The State of the Evidence on Pediatric Bipolar Disorder. The Psychiatric times.
702. Willner, P. (1984). Drugs, Biochemistry, and Conscious Experience: Toward a Theory of Psychopharmacology. Perspectives in biology and medicine. https://doi.org/10.1353/pbm.1984.0009
703. Winner, P., Hershey, A. D., & Li, Z. (2007). Headaches in Children. https://doi.org/10.1093/oso/9780195326567.003.0027
704. Winters, K. C., & Ingwalson, A. (2022). Internalizing and Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0006
705. Wissow, L. S. (2021). Anxiety and Trauma-Related Distress. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396464
706. Woo, C. H., & Kim, S. (2014). Effectiveness of the Military Mental Health Promotion Program. Journal of Korean Academy of Nursing. https://doi.org/10.4040/jkan.2014.44.6.717
707. Woo, S., & Keatinge, C. (2016). Neurodevelopmental Disorders <scp>II</scp> : Attention‐Deficit/Hyperactivity Disorder. https://doi.org/10.1002/9781394259472.ch5
708. Wu, Y., & Yin, S. (2021). A Review of Bipolar Disorder. Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research. https://doi.org/10.2991/assehr.k.211020.317
709. Wulandari, A., Kusuma, M. D., & Pancarani, R. (2023). Bipolar disorder - difficulties in managing emotional ups and down in an entertainer life: a case report. https://doi.org/10.35990/amhs.v1n3.p137-143
710. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
711. Wïttchen, H. (2001). Epidemiology of Affective Disorders. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_101
712. Yarlagadda, A. R., Brown, A. B., & Clayton, A. H. (2007). Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611h
713. Yennurajalingam, S., & Bruera, É. (2021). Fatigue. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198821328.003.0066
714. Yokoyama, H., Hirose, M., Nara, C., Wakusawa, K., Kubota, Y., Haginoya, K., Tsuchiya, S., & Iinuma, K. (2010). [A case of bipolar I disorder with autistic disorder showing "waiting-for-instruction" as a depressive symptom].. PubMed.
715. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
716. Yu, Y., & Gong, S.-P. (2008). Multiple organ supportive therapy for obstetric multiple organ dysfunction syndrome. https://doi.org/10.3321/j.issn:0376-2491.2008.11.003
717. Yung, A. R. (2011). Risk, Disorder and Diagnosis. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.3109/00048674.2011.614926
718. Yılmaz, M., Çıtak, S., & Karamustafalıoğlu, O. (2005). Psychotic disorder due to hypothyroidism: a case report. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology.
719. Zelenska, K., & Tolstaia, T. (2023). Anxiety disorders in the structure of stress-related disorders in forced immigrants. Experimental and Clinical Medicine. https://doi.org/10.35339/ekm.2021.90.3.zet
720. Zheng, Z., Zou, K., Huang, J., Yang, J., Zhou, J., Xiong, R., & Li, Y. (2023). Schizophrenia. https://doi.org/10.1007/978-981-99-4538-2_20
721. Zulkifli, N., Khuzaini, A. M., Aziz, A. A., & Awang, H. (2023). Trauma-related hallucination in an 8-year-old child with dissociative symptoms. Deleted Journal. https://doi.org/10.4103/mjp.mjp_10_23
722. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
723. Çelik, A. S., & Pasinlioğlu, T. (2013). KLİMAKTERİK DÖNEMDE YAŞANAN SEMPTOMLAR VE HEMŞİRENİN ROLÜ.
724. Žalkauskaitė, K., Varžaitė, S., & Musneckis, A. (2023). DIDŽIOSIOS DEPRESIJOS SUKELIAMOS SUDĖTINGOS BŪKLĖS. Health Sciences. https://doi.org/10.35988/sm-hs.2023.123